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ABSTRACT 
 
SAR Endolysin Regulation in dsDNA Phage Lysis of Gram-Negative Hosts.  
(December 2011) 
Gabriel Faith Kuty, B.S., Texas A&M University 
Chair of Advisory Committee: Dr. Ryland F. Young 
 
 SAR endolysins are a recently discovered class of muralytic enzymes that are 
regulated by dynamic membrane topology. They are synthesized as enzymatically 
inactive integral membrane proteins during the phage infection cycle and then are 
activated by conformational remodeling upon release from the membrane. This 
topological duality depends on N-terminal SAR (Signal-Anchor-Release) domains, 
which are enriched in weakly hydrophobic residues and require the proton motive force 
to be maintained in the bilayer. The first SAR endolysin to be characterized was P1 Lyz, 
of phage P1. Its activation requires a disulfide bond isomerization involving its catalytic 
Cys initiated by a free cysteine thiol from the newly-liberated SAR domain. A second 
mode of disulfide bond regulation, as typified by Lyz103 of the Erwinia Amylovora phage 
ERA103, has been demonstrated.   In its membrane bound form, Lyz103 is inactivated by 
a disulfide that is formed between cysteine residues flanking a catalytic glutamate.  
A second class of SAR endolysins, typified by R21, the lysozyme of the lambdoid 
phage 21, does not require disulfide bond isomerization for activation. Rather, these 
proteins are dependent on the release of the SAR domain for proper folding of the 
 iv
catalytic cleft. Bioinformatic analysis indicates that the regulatory theme of R21 is 
common in the SAR endolysins of dsDNA phages. Furthermore, bioinformatic study of 
endolysins of dsDNA phage of Gram-negative hosts revealed two new classes of SAR 
endolysins that are not homologous to T4 gpe, as all SAR endolysins were once thought 
to be. SAR endolysins were found in nearly 25% of sequenced dsDNA phages of Gram- 
negative hosts including 933W, which is involved in the release of Shiga toxin from 
EHEC strain EDL933. An inhibitor study against the SAR endolysin of 933W, R933W, 
was performed using a custom compound library in a high through-put, in vivo lysis 
assay. Of nearly 8,000 compounds screened, one compound, designated 67-J8, inhibited 
lysis but not growth. In vivo and in vitro experiments show that the compound has no 
effect on R933W activity, accumulation, or secretion. In vivo experiments suggest that 67-
J8 increases the proton motive force, thereby presumably retaining the SAR domain in 
the membrane.  
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CHAPTER I 
 INTRODUCTION 
Phage lysis timing 
In order for a progeny phage to escape a Gram-negative cell, it needs to 
overcome the three barriers that constitute the envelope: the cytoplasmic or inner 
membrane (IM), the peptidoglycan (PG) layer, and the outer membrane (OM).  For 
double-stranded DNA (dsDNA) phages, this is accomplished by lysis of the host cell.  In 
addition, the lytic event must be subject to temporal regulation, as the timing of phage 
lysis is extremely important.  If lysis occurs before the end of the eclipse period during 
which phage components are synthesized and assembled, the infection produces no 
progeny. If lysis occurs too late, the progeny may miss their opportunity for exponential 
growth.  Based on ecological theory, it has been proposed that there are two major 
factors contributing to the evolution of lysis timing: host density and host quality (1, 59, 
146, 161).  Low host density selects for a later lysis time. In this condition, progeny 
phage would accumulate linearly as long as host biosynthetic capacity and resources 
allow. High host density selects for a shorter lysis time since the progeny of a phage that 
lyses sooner will have the opportunity to infect a secondary host sooner, thus 
exponentially increasing its numbers despite the lower burst size. Host quality is also 
important, as a low quality host with limited biosynthetic resources would support the 
production of lower amounts of phage per unit time.  In the environment, host density 
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and quality may vary rapidly between extremes, so the lysis timing system must be able 
to evolve rapidly to different lysis times.  For this reason, it is thought that lysis systems 
based on holins as the timing determinants have evolved.   
 
Lambda lysis cassette 
The first dsDNA lysis system to undergo extensive study was that of the 
coliphage lambda, making its system the classic lysis paradigm. The lysis system 
includes four genes, S, the holin, R, the endolysin, and the Rz/Rz1 spanin genes (Fig. 
1.1A). Translation of the S gene can occur from one of two translational starts due to a 
dual start motif (18). Initiation at codon 1 or 3 produces S107 or S105, respectively.  
S107 is the antiholin and S105 is the holin and are each named according to its amino 
acid length. A pair of stem loops upstream of the coding sequence allows for production 
of a 2:1 ratio of S105 to S107 (17, 28). The Rz/Rz1 genes are unique in that Rz1 is fully 
imbedded in the Rz gene in a +1 register (166). The lysis genes are expressed from the 
late promoter, pR’. Upon commitment to the vegetative cycle, an anti-terminator, Q, is 
produced as a delayed early protein.  Q allows read-though of terminators by binding to 
RNA polymerase at the pR’ promoter. This prevents termination at terminators between 
the promoter and the late genes resulting in lysis gene expression. 
 
S107, the antiholin 
S105 and S107 differ by 2 amino acids but the proteins have different topologies 
(Fig. 1.1B) and opposite functions. Both proteins have three transmembrane domains 
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(TMDs), but the first TMD of S107 contains additional Met1 and Lys2 residues. The 
additional positive charge of S107 causes the retention of TMD1 in the membrane upon 
initial insertion resulting in an N-in, C-in topology (152). S105 is the prototype class I 
holin and has an N-out, C-in topology (50, 148). The N-terminus of S105 retains its 
formylated Met indicating that its TMD1 is exported to the periplasm faster than 
Escherichia coli deformylase can act (152). Mutation of the S105 start, Met3, results in 
S107 accumulation and defective lysis suggesting that the 2 additional amino acids block 
lysis (115). Furthermore, mutation of Lys2 converts S107 into a functional holin (16). 
The addition of energy poisons reverse S017’s ability to block lysis. This suggests that 
the energized membrane is required for S107 function, possibly through N-terminus 
retention in the periplasm (16). Interestingly, co-expression of SΔTMD1 with S105 
results in delayed lysis reminiscent of S107-S105 co-expression. This result indicates 
that the absence of TMD1 from the membrane is responsible for S105 inhibition (152). 
S107 was found to bind S105 as a heterodimer in the membrane indicating that S107 
mediated inhibition of S105 is by direct protein-protein interaction (54). Antiholin 
mediated S105 inhibition is only one level of lambda lysis timing. S105 contains an 
intrinsic timer dictated by its primary structure. 
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FIG. 1.1. Phage lambda lysis cassette and holin topologies. (A) Bacteriophage 
lambda uses four genes to beget lysis. S, the holin, R, the endolysin, and Rz/Rz1 of 
which Rz1 is fully imbedded in Rz in the +1 reading frame. The lysis genes are 
under the control of the late promotor, pR’ which is activated by the anti-
terminator, Q. Two proteins are expressed from a dual start motif in the S gene: 
S107, and antiholin and S105, the holin. S107 contains two additional positively 
charged amino acids than S105. (B) The additional Met and Lys of S107 give it an 
N-in, C-in topology as opposed to an N-out, C-in topology of S105.  
 
 
S hole formation 
According to the classical lysis paradigm of phage lambda, holin accumulates in 
the membrane until a genetically programmed time upon which holin triggers to form 
holes in the membrane (162). Triggering refers to the instant when holin-mediated 
disruption of the membrane occurs, monitored as cessation of cell growth and respiration 
(161). Gründling et al. (53) measured flagellar rotation speed as a direct read-out of the 
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proton motive force (PMF) in cells expressing S105. Rotation speed was constant until 
just before lysis suggesting that the accumulation of S105 does not compromise 
membrane integrity or PMF until triggering. The accumulation of holin was monitored 
by White et al. using green fluorescent protein (GFP) tagged S105 (151). During the 
morphogenesis period, S105-GFP molecules accumulate uniformly throughout the 
membrane until suddenly redistributing to a punctate pattern with the fusion protein in 
aggregates designated as ‘rafts’ (151). Presumably, the formation of rafts relates to holin 
triggering. Fluorescence recovery after photobleaching (FRAP) experiments show that 
the pre-raft state is mobile whereas the triggered state is immobile. In vivo chemical 
crosslinking shows that pre-triggering S105 accumulates in a homodimer state. S105 
crosslinking in the membranes of triggered, lysed cells was in higher order oligomers 
(51). Although raft formation and hole formation have yet to be correlated physically, 
most lysis-defective S105 mutants do not form rafts and do not oligomerize past a dimer 
stages. Based on these results and extensive genetic analysis, the current model for hole 
formation is that during late gene expression, the holin accumulates uniformly in the 
membrane as mobile homodimers. At a critical concentration of S105, the dimers 
oligomerize to nucleate large rafts. Genetic evidence suggests that this oligomerization is 
allele specific in that single amino acid changes can drastically alter lysis time (153). 
Rafts are thought to be leaky for ions leading to a local depolarization of the PMF that 
results in hole formation. Recent cryo-electron microscopy work by Dewey et al. sheds 
light on the physical nature of the hole (37). Cells expressing S105 show gaps in the IM 
ranging in size from 88 nm to 1.2 μm. Cryo-electron tomography revealed that the holes 
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were irregularly shaped and lipid-free. The average diameter of the holes was 340 nm 
making them the largest reported membrane lesions in all biology.  
 
Endolysins 
Phages use an endolysin, a muralytic enzyme, to degrade the PG. The PG of the 
Gram-negative cell wall is composed of alternating N-acetylmuramic acid (MurNAc) 
and N-acetylglucosamine (GlcNAc) sugars connected by β−1, 4 glycosidic linkages (46) 
(Fig 1.2). Sugar strands composed of 3-mers to 14-mers of alternating MurNAc-GlcNAc 
units are crosslinked by tetrapeptide chains composed of L-Ala-D-Glu-DAP-D-Ala. The 
PG forms a single, disorganized layer around the cell. This is in contrast to previous 
models that suggested that the cell wall was more regular and layered.  
Endolysins cleave a variety of bonds within the PG (Fig 1.2). Muraminidases 
such as T4 lysozyme (47, 73) and lambda R (13) cleave the β-1,4 glycosidic linkages 
between the MurNAc and GlcNAc residues while glucosaminidases (31) cleave the 
glycosidic linkages between GlcNAc and MurNAc residues. Amidases cleave the amide 
bonds between the MurNAc residues and the first L-Ala residue of the peptide crosslinks 
(66) and peptidases cleave the peptide bonds of the amino acid crosslinks (92).  
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FIG. 1.2. E. coli PG and endolysin targets. The bacterial cell wall is composed of 
PG. PG is made up of repeating units of N-acetyl muramic acid (MurNAc)-N-acetyl 
glucosamine (GlcNAc) disaccharide. The GlcNAc and MurNAc units are connected 
by a β-glycosidic linkage. Tetrapeptide crosslinks composed of L-Ala-D-Glu-DAP-
D-Ala connect the repeating GlcNAc - MurNAc chains. Endolysins cleave various 
bonds within the PG. 
 
 
T4 lysozyme mechanism 
The T4 lysozyme, E, is classified as a 1, 4-β-acetyl-muraminidase (47, 73) (EC 
3.2.1.17). E uses a hydrolase mechanism and has a catalytic triad composed of a Glu 
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followed by 5 amino acids, an Asp or Cys followed by 8 amino acids, and a Thr (E-5x-
D/C-8x-T) (Fig. 1.3). In the proposed catalytic mechanism, the Glu residue acts as an 
acid to protonate the glycosidic linkage (58). It was originally thought that the 
contribution of the Asp was to stabilize the resulting oxocarbonium intermediate; 
however, the discovery that a D20C mutant retained 80% activity shifted the importance 
of this residue. At physiological pH, a Cys would remain protonated. Thus in its 
uncharged state, it would be less likely to stabilize an intermediate electrostatically; 
however, a sulfhydryl at this position would make an ideal nucleophile (73). Recently it 
was proposed that a nucleophile in the middle catalytic triad position abstracts a proton 
from a water molecule, which then attacks C1. The Thr interacts with and stabilizes the 
water molecule involved in the hydrolysis of the glycosidic bond. What results is a 
single nucleophilic substitution reaction in which the remaining PG chain is the leaving 
group along with the glycoside oxygen.  
 9
 
 
                   
FIG. 1.3. T4 lysozyme mechanism. The T4 lysozyme, E, uses an E-8x-D-5x-T 
catalytic triad and acts as a hydrolase. Asp 20 removes a proton from a water 
molecule stabilized by Thr26 (73). The Thr26-stabilized hydroxyl then attacks the 
C1 position of the MurNAc moiety. A proton is abstracted from Glu11 resulting in 
a single displacement reaction. The mechanism inverts the position of the C1 
hydroxyl from the β conformation to the α conformation.  
 
 
Transglycosylase mechanism 
The catalytic center of the transglycosylase is structurally similar to that of the 
lysozyme, except for the presence of only a single catalytic residue (120). As with the 
lysozyme reaction, the proposed transglycosylase mechanism uses a catalytic carboxylic 
acid to protonate the glycosidic linkage releasing the GlcNAc moiety (Fig. 1.4). A stable 
muramoyl oxazolinium-ion intermediate is formed involving the N-acetyl group of the 
MurNAc residue. The catalytic Glu then acts as a base to remove the C6 hydroxyl proton 
of the intermediate. An intramolecular, nucleophilic attack at C1 by the C6 oxygen 
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collapses the intermediate resulting in the formation of a non-reducing, 1, 6-anhydro-N-
acetyl-muramoyl product. 
 
 
 
     
FIG. 1.4. Lytic transglycosylase mechanism. Transglycosylases cleave the β-1,4 
glycosidic bond between MurNAc and GlcNAc moieties of PG. A catalytic 
glutamate acts as an acid to protonate the bond to release the GlcNAc moiety (120). 
The same Glu then acts as a base to remove a proton from the C6 hydroxyl of the 
remaining MurNAc residue forming a resonance stabilized intermediate. The 
intermediate collapses to form a 1, 6-anhydro-N-acetyl-muramoyl product. 
 
 
Lambda R 
Bacteriophage lambda uses a transglycosylase, R, to degrade the PG. R 
accumulates concomitantly with holin accumulation during late gene expression (148) 
(Fig. 1.5) . R is an 18KDa soluble protein that accumulates in the cytoplasm in a fully 
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folded, enzymatically active conformation (13). Since it is sequestered in the cytoplasm, 
R accumulates with no disruption of cellular structural integrity. After hole formation, R 
passes through the lesions in the cytoplasmic membrane barrier and degrades the PG. It 
was originally thought that the resulting disruption of the murein layer was necessary 
and sufficient for lysis. With no barrier to withstand the turgor pressure of the cell, the 
cell would burst, releasing progeny phage. This notion has recently been challenged by 
the results of bioinformatic, biochemical, and genetic study of the Rz/Rz1 spanins (11, 
12, 132). 
 
 
 
 
FIG. 1.5. The lambda lysis paradigm. Bacteriophage lambda surpasses the cellular 
envelope using four proteins. S105, the holin, accumulates in the IM while R, the 
endolysin, accumulates in the cytoplasm. Rz and Rz1, the spanins, form a laterally 
immobile complex across the periplasm with Rz and Rz1 in the IM and OM, 
respectively. Upon holin triggering and lesion formation, R passes through the hole 
and degrades the PG followed by spanin mediated OM disruption. 
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Rz and Rz1, the spanins 
Rz was initially thought to be a missing endopeptidase whose activity had been detected 
in lambda phage lysates (138). Under standard laboratory conditions (aerobic liquid 
culture, vigorous shaking at 37°C), only S105 and R are required for lysis.  Under these 
conditions, defects in Rz/Rz1 prevent lysis only in the presence of >10mM Mg2+. Due to 
this conditional phenotype, Rz and Rz1 were considered accessory lysis proteins (148). 
Since S105 and R are sufficient for lysis under standard laboratory conditions, it was 
thought that the PG degradation by R was so complete that cell lysis followed. 
Furthermore, since the Rz/Rz1 conditional lysis defect was only apparent after OM 
stabilization, it was thought that the Rz/Rz1 role in lysis was at the OM. The PG is 
linked to the OM by > 300,000 oligopeptide links between Braun’s lipoprotein, Lpp, and 
the PG (22, 141). It was hypothesized that Rz/Rz1 has an endopeptidase activity to 
release the PG from its crosslinks (166).  
Recently, work by Berry et al. (11, 12, 132) has redefined the previous model of 
dsDNA phage lysis, and has removed the label of “accessory” from Rz and Rz1. Rz has 
an N-terminal hydrophobic sequence predicted to be a TMD or a secretory signal. Rz1 
contains a putative signal peptidase II cleavage site and a lipoylation signal. The 
locations of Rz and Rz1 have been confirmed as the IM and the OM, respectively, with 
both proteins embedded in their corresponding membranes (12). The periplasmic 
domains of Rz/Rz1 were shown by circular dichroism to form a complex that undergoes 
a conformational change that adds alpha-helicity. This complex formation between Rz in 
the IM and Rz1 in the OM, across the periplasm, leads to the term ‘spanin’ to describe 
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the Rz/Rz1 proteins. Further evidence for Rz/Rz1 complex formation comes from 
transmission-electron microscopy studies showing that when mixed, the periplasmic 
domains of Rz and Rz1 form a single particle with a coil-like pattern (11).  
The ubiquity of spanins was shown in a comprehensive bioinformatic survey 
performed of dsDNA phages of Gram-negative hosts. Rz/Rz1 equivalents were found in 
most (88%) of the phages analyzed (132). Four gene arrangements were found 
including: the fully embedded arrangement found in lambda, overlapped genes like those 
in phage P2 in which the Rz1 equivalent extends past the end of the Rz equivalent, fully 
separated genes, and even single gene equivalents like T1 gp11. Gp11 has a C-terminal 
TMD and an N-terminal lipoylation signal and was shown to compliment a lambda 
Rz/Rz1 defect, despite little to no sequence homology. This finding suggests that Rz and 
Rz1 form a complex linking the IM and OM across the periplasm (132).  
The classic lysis paradigm now consists of a three stage process in which each 
step is required for the next (Fig. 1.5). First, the holin accumulates evenly throughout the 
membrane while the endolysin accumulates in the cytoplasm. The Rz/Rz1 proteins 
accumulate in the IM and OM, respectively, and form a complex across the periplasm. 
Presumably, this spanin complex is relatively immobile due to the constraints of the PG 
meshwork (11). In the moments before lysis, the holin oligomerizes and forms rafts in 
the membrane. A local depletion of the PMF leads to hole formation allowing escape of 
the endolysin resulting in PG degradation. Without the constraint of the PG, the Rz/Rz1 
complex would be able to oligomerize laterally. Although the exact mechanism of 
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Rz/Rz1 function is not known, it has been suggested that the spanin collapses into a 
coiled coil conformation, fusing the inner and outer membranes, lysing the cell (12).  
 
Phage lysis of Gram-positive cells 
Phage-mediated lysis of Gram-positive cells occurs in a similar manner to Gram- 
 negative cells. In phages of Gram-positive hosts, typically the “lysis cassette” contains 
the holin and R encoding the endolysin, usually referred to as a lysin. Due to the lack of 
an OM, Gram-positive phages do not have Rz/Rz1 equivalents. Mycobacteria are unique  
among Gram positives in that they have an external mycolic acid layer that has proteins 
mounted in it, effectively making it an OM (169). The mycolic acid OM is attached to an 
arabinogalactan (AG)-PG layer by ester linkages. To overcome this barrier, 
mycobacteriophages encode an additional lysis protein, Lysin B, a mycolyl-
arabinogalactan esterase (111, 118). Lysin B cleaves the ester bonds linking the OM to 
the AG-PG, releasing the mycolic acid layer.   
The holins of phages of Gram-positive hosts are proposed to be functionally 
similar to those of Gram-negative phage (135). Gram-positive endolysins share activities 
with Gram-negative endolysins (muraminidase, peptidase, amidase), although their 
architecture tends to differ (42). Most Gram-positive endolysins are modular in 
organization in that they have an N-terminal catalytic domain and a dedicated C-terminal 
substrate binding domain called the cell wall binding domain (CWBD). Some Gram- 
positive endolysins have multiple catalytic domains. For example, the Staphylococcus 
aureus phage Φ11 has a D-alanoyl-glycyl-endopeptidase domain and an N-
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acetylmuramoyl-L-alanine amidase domain followed by a CWBD (98). The CWBDs of 
Gram-positive lysins are very specific and have high affinity for their substrate. PG 
varies among bacterial species (122) and Gram-positive lysins have specificity for the 
host PG they were produced from (42). Streptococcus pneumonia phage lysins, for 
instance, kill various strains of group A Streptococcus, but not other strains of oral 
commensal Streptococcus (82). Surface plasmon resonance experiments by Loessner et 
al. measured association constants of Gram-positive lysins for their substrate and found 
them to be in the nanomolar range (representing strong binding), thus endolysins may be 
one-time use molecules that remain attached to the PG (83). This characteristic would be 
valuable in the context of a phage infection by preventing diffusion. Gram- positive cells 
are sensitive to the action of exogenous lysins (42). A free lysin not bound to PG could 
prematurely lyse a neighboring infected cell resulting in a non-productive infection (83). 
It was originally thought that phages of Gram-positive hosts use a lysis 
mechanism that was the same as their gram negative counterparts. As with the classic 
lysis paradigm of lambda, the holin of Gram-positive phages is responsible for lysis 
timing. Recently, a new Gram-positive lysis paradigm has begun to emerge. The lysin, 
Lys44, from the Oenococcus oeni phage fOg44 was found to have a hydrophobic N-
terminal region such as that found in a signal sequence (118). Experiments showed that 
Lys44 encoded a signal peptide and was exported in its mature, cleaved form. This result 
was unexpected since the phage also encoded a holin. Up to this point, it was 
hypothesized that phages required a holin for endolysin export since none of the 
characterized endolysins contained a signal sequence (129).  
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During phage infection studies, mature, processed Lys44 began to accumulate 80 
minutes after infection despite a 150 minute latent period (118). The authors concluded 
that the phage must have a regulation system to keep Lys44 inactive until it is needed. A 
model was proposed in which the holin regulates Lys44 by mimicking the cellular 
mechanism that regulates autolysins involved in cell wall turnover. Support for this 
comes from reports by Jolliffe et al. showing that Bacillus subtilus autolysins are 
activated by the addition of energy poisons, suggesting that the energized membrane 
plays a role in regulating cellular autolysis (67). Although the exact mechanism for this 
regulation is not understood, it has been proposed that the chemical and structural 
environment of the energized membrane inhibits autolysins. Changes in membrane 
characteristics such as permeability (71) and fluorescent probe binding (32, 99) have 
been observed after depletion of the PMF. This indicates that the membrane environment 
differs with and without the PMF. 
 
SAR endolysins: A new lysis paradigm 
Recently, a new paradigm for dsDNA phage lysis of Gram-negative hosts has 
emerged. As with phage fOg44, it was observed that some phages of Gram-negative 
hosts also encoded endolysins that have a hydrophobic N-terminal domain similar to that 
of a signal sequence. The lysozyme, Lyz, of phage P1 was found to have such an 
extension and was chosen for detailed study (159). When Lyz was expressed without a 
holin, it caused lysis of the host culture suggesting host-mediated secretion of the 
enzyme. Indeed, Lyz mediated lysis could be prevented by the addition of azide, a SecA 
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inhibitor. Furthermore, a sub-cellular fractionation of cells expressing Lyz showed that 
the protein was partitioned both into the membrane and soluble fractions of the cell. 
Surprisingly, however, the apparent molecular masses of the soluble and membrane 
bound Lyz were the same, indicating that the secretion was not associated with signal 
peptide cleavage. Taken together, the data indicated that the N-terminal domain was 
responsible for: a) secretion of the protein through the Sec pathway, b) tethering the 
protein to the cytoplasmic membrane, and c) releasing the protein into the periplasm 
(Fig. 1.6). The domain was thus called a Signal Anchor Release, or SAR domain. 
 
P1 Lyz 
Since the lysis genes are expressed simultaneously with all of the genes required 
for morphogenesis, a secreted enzyme must be maintained in an inactive state to prevent 
premature lysis of the host cell. This regulation was first studied in detail in P1 Lyz. 
Sequence analysis showed that Lyz has a catalytic triad of E-5x-C-8x-T. This is similar 
to that of the T4 lysozyme, E, which has an E-5x-D-8x-T triad (Fig. 1.7). Mutagenesis 
studies of T4 E show that a catalytic D to C mutation was very well tolerated showing an 
activity 80% that of wild type E (58). To date, all SAR endolysins studied are homologs 
of T4 E. It was observed that Lyz had two cysteines (C13 in the SAR domain and C44) 
N-terminal to its catalytic C51. The E. coli protein DsbA forms disulfide bonds with 
consecutive cysteines as they emerge in the periplasm (8). It was therefore hypothesized 
that a disulfide bond would form between C44 and the catalytic C51, leaving the 
membrane sequestered C13 in its sulfhydryl form (Fig. 1.8). This lead to an elegant 
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model in which an inactivating disulfide was formed between C44 and C51 and upon 
release from the membrane, the SAR sulfhydryl at C13 would attack C44, forming a 
new disulfide bond. This disulfide bond isomerization was hypothesized to release C51, 
activating the protein (159).  
 
 
 
 
 
FIG. 1.6. The SAR endolysin paradigm. Unlike the classic lysis paradigm, the 
SAR endolysin paradigm uses a secreted endolysin. (A) The SAR endolysin is 
secreted by virtue of its N-terminal Signal Anchor Release domain via the Sec 
translocon. The SAR domain anchors the endolysin to the cytoplasmic membrane 
in an inactive conformation. (B) Upon membrane depolarization, the SAR domain 
is released from the membrane, activating the protein.  
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FIG. 1.7. Alignment of phage lysozymes. The lysozyme of phage T4, E, has a 
catalytic triad composed of E-5x-D-8x-T. Homologs of T4 E use this triad, 
maintaining the spacing between residues, although in some, a catalytic Cys 
replaces the catalytic Asp. Here, homologs of T4 E are aligned by their catalytic 
residues (highlighted in yellow) and Cys residues are highlighted in blue. SAR 
endolysins are homologs of T4 E (SAR domains underlined). 
 
 
 
FIG. 1.8. P1 Lyz activation by disulfide bond isomerization. In its membrane bound 
form, P1 Lyz is inactive due to a disulfide bond formed between a catalytic Cys and 
a non-catalytic Cys (left panel). Upon release from the membrane, the SAR domain 
Cys initiates a disulfide bond isomerization to release the catalytic Cys (star, right). 
(Figure reprinted with permission from AAAS.)
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The alternative disulfide bonding pattern was demonstrated in vivo using a 
sulfhydryl cyanylating chemical, 1-cyano-4-dimethylaminopyridinium (CDAP) (156). 
Treatment of a cyanylated protein with a strong base such as ammonium hydroxide 
cleaves the protein on the N-terminus of the cyanylated cysteine. When Lyz was cleaved 
before and after lysis using this method, two distinct cleavage products were observed 
confirming the disulfide bond isomerization. The crystal structure of Lyz was solved by 
Arockiasamy Arulandu and Stephanie Swanson in the laboratory of Jim Sacchettini 
(Texas A&M University) (Fig. 1.9). To obtain the inactive form of Lyz (Lyzi), the 
periplasmic domain of the protein was crystallized. Full length Lyz was purified and 
crystallized for the active form (Lyza). The structures show several interesting features. 
First, Lyz displays the classic lysozyme fold (150) with an N-terminal catalytic domain 
and a C-terminal helix bundle connected by an inter-domain helix . The structural 
rearrangement required to activate the enzyme is also apparent. The catalytic cleft of the 
periplasmic domain of Lyz was found to be in an inactive conformation with: a) the side 
chains of the catalytic Glu42 and Thr57 residues pointing outwards and b) a bend in the 
inter-domain helix (Fig. 1.9 left). The catalytic cysteine of Lyzi was maintained in a 
disulfide bond with Cys44 in the vicinity of the active site. Upon activation of the 
enzyme by the disulfide bond isomerization, three helices in the N-terminal domain 
unwind to form three beta strands that form a sheet (Fig. 1.9 right). This shift in 
secondary structure repositions the newly freed catalytic Cys51, rotates the catalytic 
Glu42 and Thr57 inward to form the active site, and relieves a bend in the inter-domain 
helix. The active structure also shows the newly formed Cys13-Cys44 disulfide. 
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FIG. 1.9. Comparison of inactive and active forms of P1 Lyz. The inactive form of 
P1 Lyz (Lyzi, left) and active forms of P1 Lyz (Lyza, right) are shown. Upon release 
of the SAR domain, a large structural rearrangement occurs that creates the catalytic 
cleft of activate the enzyme. Catalytic residues (red), disulfide bonds (stick form), 
Cys residues involved in the disulfide bond isomerization (green), and the SAR 
domain (blue) are indicated. 
 
 
In the disulfide bond isomerization regulation mechanism, the role of the SAR 
domain is two-fold. First, the SAR domain targets the protein for secretion and releases 
it from the membrane, but this function was found not to be unique to the P1 Lyz SAR 
domain. When the SAR domain was replaced with the cleavable signal sequence of 
PhoA, Lyz was still targeted to and released into the periplasm, although activation 
required addition of exogenous reducing agent. The second function of the Lyz SAR 
domain is to provide the free sulfhydryl that initiates the disulfide bond isomerization. 
This function was also found not to be unique to the Lyz SAR domain. When the Lyz 
SAR domain was replaced with the cysteine-less SAR domain from the SAR endolysin 
of phage 21, R21, the resulting chimera was not lytic. However, the addition of a Cys on 
 22
the proper, protein-interacting face of the SAR domain in this chimera restored lysis. 
This indicates that the Lyz SAR domain itself is not responsible for the large structural 
rearrangement that activates the enzyme; rather it is the release of the inactivating 
disulfide by the SAR sulfhydryl or addition of exogenous reducing agent that triggers the 
conformational change. 
 
The SAR domain 
SAR domains are composed of an over-representation of weakly hydrophobic 
and polar, non-charged residues such as Ala, Gly, Ser, and Thr (80, 100, 159). The over-
representation is compared to TMDs that contain mostly Leu, Ile, and Val residues (41, 
155). Presumably, the weakly hydrophobic nature of the SAR domain supports its 
release from the cytoplasmic membrane. A SAR domain first acts as a TMD so it must 
span the cytoplasmic membrane. Membrane spanning segments are typically alpha-
helices and are 17-35 residues in length on average (68). Preliminary research suggests 
that SAR domains form a single helix in a lipidic environment (J. Deaton, unpublished 
data). Addition of energy poisons such as dinitrophenol or cyanide promote premature 
release of the SAR domain from the membrane suggesting that SAR domains are 
maintained as meta-stable membrane helices in the context of an energized membrane. 
An interesting feature of a SAR domain is its ability to retain solubility in an 
aqueous environment after release from the membrane thus allowing the SAR domain to 
fold into the now soluble, active protein. This is a very interesting feature from a 
thermodynamic standpoint. A SAR domain must be hydrophobic enough to be 
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recognized by the Sec translocon and partitioned into the membrane, but it must also be 
somewhat neutral as to not alter the protein’s structure upon release. Typically, exposure 
of a hydrophobic sequence to the aqueous environment would result in aggregation due 
to the hydrophobic effect (137), yet the SAR domain has evolved a delicate balance as to 
achieve stability and functionality in both environments. This balance of hydrophobicity 
can be disturbed by converting Gly or Ala residues to Leu residues, as these mutations 
block the ability of the SAR domain to exit the bilayer. This feature is protein specific 
i.e. 3 Gly to Leu substitutions are needed to retain P1 Lyz in the membrane and 2 
substitutions are required to retain the SAR domain of R21 (74, 133).  
 
ERA103 
Phage ERA103 infects the Gram-negative plant pathogen Erwinia amylovora, 
the causative agent of fire blight in fruit producing plants, such as pear and apple trees 
(104). Current treatment for the crop eradicating disease is streptomycin, but success of 
treatment is fading due to the increase in resistance among E. amylovora populations. 
Recent studies have suggested the use of phage to control the pathogen. In 2004, a 
German group looked to the lysozyme of E. amylovora phage ΦEa1h as a potential 
control mechanism. The lyz gene from φEa1h was cloned and IPTG induced LyzEa1h was 
found to lyse cells (70).  
The sequence of lyz from ΦEa1h is identical to that of lyz103 from E. amylovora 
phage ERA103. The protein has 51% similarity and 33% identity with P1 Lyz, 
suggesting that Lyz103 is a T4 E homolog. Further examination of the sequence shows 
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the presence of an N-terminal stretch of 21 weakly hydrophobic amino acids reminiscent 
of a SAR domain. A Cys is present in the putative SAR domain indicating the potential 
for a disulfide bond activation mechanism similar to P1 Lyz. Unlike P1 Lyz, Lyz103 does 
not have a catalytic Cys, but rather uses the canonical Asp residue. Thus, if disulfide 
bond rearrangement is involved in its activation, then the mechanism must be different. 
 
Phage 21 
The lambdoid phage 21 is another example of the SAR endolysin-mediated lysis 
paradigm (133, 159). So far, the study of phage 21 has had the most impact in 
determining the role of the holin in the SAR lysis system. In the classic lysis paradigm, 
the holin controls lysis timing by forming lesions in the IM allowing passage of the 
endolysin into the periplasm where it can degrade the PG. In the SAR lysis system, 
however, the endolysin begins in the periplasm, so the question was posed: “how does 
the holin control lysis timing in the SAR lysis paradigm?” Initial study of the SAR 
endolysin showed that the SAR domain can be released prematurely by simple 
membrane depolarization (159). Thus, it was hypothesized that the holin regulates lysis 
timing by causing the collapse of the PMF in a temporally regulated manner. Initial 
studies of S21, the phage 21 holin, show that it cannot complement an Sam mutation in the 
lambda lysis cassette, despite accumulation of active endolysin (108). This data suggests 
that S21 forms small holes that do not allow passage of lambda R into the periplasm. S21 
has been termed a “pinholin” to highlight the small size of the holes.  
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S21, the pinholin 
The lysis cassette of phage 21 contains a holin, S21, SAR endolysin, R21, and 
Rz/Rz1 genes (Fig. 1.10A). Like phage lambda, S21 uses a dual start motif to express two 
proteins: S2168, the holin and S2171, the antiholin (109). S2168 is the prototype class II 
holin with two TMDs arranged in an N-in, C-in topology (Fig 1.10B).  
 
 
 
 
 
FIG. 1.10. Phage 21 lysis cassette and holin topologies. (A) The lysis cassette of 
lambdoid phage 21 is composed of a S21, R21, and Rz/Rz1. S21 uses a dual start 
motif to encode S2171, the antiholin and S2168, the holin. (B) S2168 is a class II 
holin and has 2 TMDs in an N-in, C-in topology (109). TMD1 is a SAR domain 
that exists the membrane in the pathway to hole formation (106). 
 
 
 26
Interestingly, the first TMD is composed largely of weakly hydrophobic residues 
reminiscent of a SAR domain. When the SAR domain of P1 Lyz was replaced with the 
S2168 TMD1, the full-length chimeric protein S2168TMD1ΦLyzΔSAR was present in the 
periplasm. This is consistent with the hypothesis that S2168 TMD1 is a SAR domain. To 
determine if TMD1 actually exits the bilayer within the context of the holin, Park et al. 
replaced Ser16 of TMD1 with a Cys (109). The prediction was that if TMD1 exits the 
membrane to the oxidizing environment of the periplasm, and if S2168 molecules could 
oligomerize, then disulfide linked dimers would be observed. Membranes of cells 
expressing S2168S16C indeed contained disulfide linked dimers indicating that TMD1 
leaves the membrane, perhaps on the pathway to hole formation. Genetic and 
biochemical studies by Pang et al. indicate that the pinhole is composed of a heptamer of 
S2168 with a lumen of < 2nm (107). Interestingly, not all SAR endolysins are coupled 
with pinholins (108). The holin of phage P1, LydA, forms large holes as seen by 
complementation of a lambda Sam mutation (157). As a consequence, it cannot be 
concluded that all SAR endolysins are served by pinholins. 
 
R21: A new class of SAR endolysin 
As with any lysis system, the endolysin of 21 needs regulation to prevent 
premature lysis. With P1 Lyz, this is accomplished by a disulfide bond isomerization 
initiated by the SAR domain Cys. Inspection of the R21 primary structure shows no Cys 
residue in the SAR domain. Since there is no Cys in the SAR domain, R21 cannot be 
regulated by a disulfide bond isomerization like P1 Lyz. This makes R21 the prototype of 
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a new sub-class of “Cys-less” SAR endolysins. Interestingly, bioinformatic analysis of 
putative SAR endolysins suggests that R21-like proteins are predominant over P1-Lyz 
like SAR endolysins, at least among sequenced phages. 
 
933W 
The lambdoid phage 933W has gained significant attention recently in the field 
of human disease, specifically Entero-hemorrhagic Escherichia coli (EHEC) serotype 
O157:H7, the causative agent of hemorrhagic colitis and hemolytic-uremic syndrome 
(136). EHEC produces the Stx2 toxin in the AB5 Shiga family of toxins (78). The Stx2 
toxin is a complex composed of a monomer of subunit A and a pentamer of subunit B. 
Subunit A is an N-glycosidase that cleaves an adenine residue from the 28S RNA of the 
60S ribosomal subunit, rendering it inactive. The B pentamer is responsible for cell 
recognition via the Gb3 glycolipid receptor, and for internalization of the A toxin. 
The genes encoding the Stx2 toxin are under control the late promoter, pR’, of 
the 933W prophage (Fig. 1.11). While EHEC strain EDL933 has many prophages, only 
prophage 933W can actively produce phage (61). As with lambda, 933W pR’ is induced 
upon prophage induction as a result of SOS-dependent DNA damage (145). Activation 
of pR’ induces the morphogenesis, lysis, and concomitantly, the Stx2 genes (144). The 
fact that phage induction results in toxin expression explains why DNA damaging 
antibiotics such as norfloxacin, a gyrase inhibitor, exacerbate EHEC infections (167). 
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FIG. 1.11. Phage 933W lysis cassette. As with phage lambda, the lysis genes of 
prophage 933W of EHEC strain O157:H7 are expressed from the late pR’ promotor 
which is induced by the anti-terminator, Q. The 933W lysis cassette consists of a 
pinholin (S), a SAR endolysin (R, star), and spannin genes (Rz/RZ1). Also expressed 
from the late promotor are the Stx A and B shiga toxin genes.  
 
 
In EHEC strains induced for the 933W prophage, Stx2 is found extracellularly 
(124). EHEC contains the LEE pathogenicity island that encodes a type III secretion 
system (5). The secretion system supports the release of proteins responsible for cell 
adhesion, but not the Stx2 toxin. It was hypothesized that since the phage lysis genes and 
toxin genes are co-transcribed, perhaps phage induced lysis provides a mechanism for 
toxin release. Indeed, 933W ΔSR prophage induction results in complete cell association 
of Stx2 suggesting that the phage’s lysis machinery alone is responsible for toxin 
release. Inspection of the 933W lysis cassette shows the presence of a putative SAR 
endolysin, R933W. Other stx containing phages such as VT2-Sakai, Stx2-φII, and the 
prophage of the recent Germany outbreak strain contain endolysins identical to R933W 
(87, 113, 116, 119). As described above, SAR endolysins are initially secreted to the 
cytoplasmic membrane in an inactive conformation. In the context of a phage infection 
or prophage induction, presumably, SAR endolysins are released synchronously due to 
membrane depolarization by the holin. In the absence of a holin, however, SAR 
endolysins gradually release from the membrane. Membrane release results in a 
 29
refolding event that activates the enzyme (133, 159). Thus, a SAR endolysin expressed 
alone can cause lysis of the host cell. Keeping in mind the vital role phage mediated lysis 
plays in shiga toxin release; R933W is a potential drug target in EHEC infections.   
 
Project aims 
The goals of this dissertation research are to: 
1) Determine if other modes of disulfide bond regulation of SAR endolysins exist 
and, if so, characterize them. 
2) Define the mechanism of regulation in SAR endolysins with no cysteine in the 
SAR domain. 
3) Establish the prevalence of the SAR endolysin within dsDNA phage lysis of 
Gram-negative hosts. 
4) Determine the value of the SAR endolysin as a drug target in EHEC O15:H7 
infections. 
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CHAPTER II 
REGULATION OF A PHAGE ENDOLYSIN BY DISULFIDE 
CAGING* 
Introduction  
 In infections by double-stranded DNA phages, host lysis requires degradation of 
the peptidoglycan by a phage-encoded endolysin (148).  By far the most intensively 
studied endolysin is the T4 lysozyme, E (EC 3.2.1.17), which attacks the glycosidic 
bonds between GlcNAc and MurNAc in the murein (7). During the latent period, 
canonical endolysins are produced as fully active enzymes sequestered in the cytoplasm, 
thereby preventing premature lysis.  Another phage protein, the holin, terminates the 
infection cycle by forming extremely large, non-specific holes in the membrane, which 
allow the endolysin to escape and attack the murein layer (163).   Recently, studies on 
the lysis system of bacteriophage P1 have revealed that phage-encoded endolysins are 
not always dependent upon holins for export (158, 159).  Although it is an ortholog of 
T4 E, the P1 lysozyme, P1 Lyz, is translocated across the cytoplasmic membrane by the 
host sec system, by virtue of an N-terminal transmembrane domain (TMD) absent in E 
(Fig. 2.1A).  Since this transmembrane domain is not removed by signal peptidase, 
nascent P1 Lyz remains tethered to the membrane with its catalytic residues already 
present in the periplasm.  The P1 Lyz TMD exits the membrane and  
 
____________ 
*Reprinted with permission from “Regulation of a phage endolysin by disulfide caging” 
by Kuty, G.F., M. Xu, D.K. Struck, E.J. Summer, and R. Young, 2010. Journal of 
Bacteriology, 192, 5682-5687. Copyright 2010 by ASM Press. 
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becomes a part of the soluble, periplasmic form of the protein, either at a slow 
spontaneous rate or, more efficiently, when the holin triggers to depolarize the 
membrane (109).  Because of the unique ability to direct sec-mediated export and 
membrane insertion and also to support release into the periplasm from the bilayer, the 
TMD of P1 Lyz was designated as a SAR (signal anchor release) domain.  More 
recently, other SAR endolysins have been identified and characterized (130, 133).  In 
fact, bioinformatic analysis suggest that most members of the T4 lysozyme family, 
recognizable by the Glu-8x-Asp/Cys-5x-Thr catalytic triad (Fig. 2.1A), are SAR 
endolysins (43 of 58 entries in the Genbank Protein database) (133).  
Since the P1 Lyz gene is expressed well before progeny phage have been assembled, 
there must be a mechanism to ensure that the membrane-tethered form of the protein is 
kept enzymatically inactive so that premature lysis is avoided.  A key to the regulation of 
P1 Lyz is the fact that the P1 enzyme has a catalytic cysteine residue, Cys51 (Fig. 2.1A), 
in the central position of the catalytic triad, in contrast to E and most of its orthologs, 
which have an Asp in this position (159). Genetic, biochemical, and structural analysis 
of P1 Lyz demonstrated that the membrane-tethered form is inactive for two reasons: 
first, the entire catalytic domain is misfolded, so that the active site cleft is completely 
missing; and second, the catalytic Cys51 is covalently occupied in a disulfide bond with 
another Cys at position 44.   This led to a model for activation in which a thiol (Cys13) 
present in the SAR domain becomes unmasked upon membrane release and triggers a 
disulfide-bond isomerization, liberating the thiol of the catalytic Cys51. This model was 
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confirmed by crystal structures showing the alternative disulfide linkages in the inactive 
and active forms of P1 Lyz (158). 
 
 
 
 
 
 
FIG. 2.1. Sequence alignments. (A) Alignment of T4E, P1 Lyz, and Lyz103. 
Catalytic residues are highlighted in blue, Cys residues in pink, and SAR 
domains in yellow. Locations of Leu substitutions are indicated below the 
corresponding Gly (green). Inactivating/caging disulfides for P1 Lyz and Lyz103, 
respectively, are shown as a black connected arrow above the participating Cys 
residues. Disulfides resulting from isomerization are shown below the 
participating Cys residues as brown connected arrows. (B) Alignments of P1 
Lyz?103 and Lyz103?P1 conversion mutants. Catalytic residues are highlighted in 
blue, Cys residues in pink, and SAR domains in yellow. Locations of Cys 
substitutions are indicated below the corresponding residue. 
 
 
 P1 Lyz became the prototype of a class of SAR endolysins recognizable by the 
Asp → Cys substitution in the catalytic triad and the presence of activating Cys in the N-
terminal SAR domain.  However, most SAR endolysins belong to a second major class, 
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represented by R21, the endolysin of the lambdoid phage 21 (159).  These enzymes have 
the canonical Glu-8x-Asp-5x-Thr catalytic triad and no Cys residue in the SAR domain.  
Instead, genetic and structural analysis revealed that in the inactive form, the catalytic 
domain has nearly the correct fold, except for a displacement of the active site Glu, but 
is subject to steric hindrance by the proximity of the bilayer in which the SAR domain is 
embedded.  In the soluble, active form, the SAR domain of R21 has refolded into the 
main body of the enzyme, providing a floor to the active site and repositioning the 
catalytic glutamate to its proper place (133).  Thus the R21 regulatory scheme is 
markedly different from that of P1 Lyz, where the released SAR domain provides only 
the free thiol for the disulfide bond rearrangement and makes few contacts with the 
enzyme itself. 
 Here we examine the regulation of the endolysin Lyz103of the Erwinia 
amylovora phage ERA103 (GenBank: EF160123), which has characteristics of both of 
these major classes: it has a Cys residue in an N-terminal hydrophobic sequence but 
retains the canonical Asp residue in the catalytic triad.  The results are discussed in terms 
of a model for SAR-dependent disulfide bond isomerization distinct from that of P1 Lyz 
and its homologs but which nevertheless confers a covalent constraint on premature 
activation of the muralytic activity.  
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Materials and methods  
 
Bacterial strains and growth conditions   
 The Escherichia coli strains XL1-Blue, MC4100, and MG1655 ΔtonA lacY- lacIq 
have been described (127, 133). Standard conditions for the growth of cultures and the 
monitoring of lysis kinetics have been previously described (29, 127).  All bacterial 
cultures were grown in standard LB medium, supplemented with 100 μg/ml ampicillin 
when appropriate. When indicated, isopropyl β-D-thiogalactopyranoside (IPTG), 
dinitrophenol (DNP), and dithiothreitol (DTT) were added to final concentrations of 1 
mM, 10 mM, and 1 mM respectively.   
 
DNA procedures and plasmid construction   
 Procedures for the isolation of plasmid DNA, DNA amplification by PCR, PCR 
product purification, DNA transformation, site-directed mutagenesis, and DNA 
sequencing have been previously described (52, 126, 128).  The construction of the 
plasmid pP1 Lyz, a derivative of pJF118EH, has been described previously (45, 159).  
The plasmid pLyz103 was constructed by amplifying and inserting lyz103 between the 
EcoRI and HindIII restriction sites of pJF118EH.  Similarly, the construct, pETLyz103 
was constructed by amplifying lyz103 and inserting it between XbaI and BamHI of 
pET11a (Novagen).  For over-expression purposes, the inactive allele lyz103D52N was 
used. Derivative alleles of lyz103 and P1 Lyz were made using site-directed mutagenesis.  
For detection and purification purposes, the lyz103 allele was modified to encode an 
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oligohistidine tag (Gly2His6Gly2) appended to Met178 by site-directed mutagenesis.  All 
purified protein cited in this work refers to the oligohistidine-tagged version. 
 
SDS-PAGE and Western blotting   
 SDS-PAGE, Western blotting, and immunodetection experiments were 
performed as previously described (52).  Antiserum against P1 Lyz was prepared in 
chickens by Aves Labs (Tigard, OR) and was used at a dilution of 1:1,000.  A mouse 
monoclonal antibody against the oligo-histidine epitope tag was purchased from 
Amersham and was used at a dilution of 1:3,000.  Horseradish peroxidase-conjugated 
secondary antibodies against chicken IgY were purchased from Aves Labs, and were 
used at a 1:2000 dilution for colorimetric detection, and a 1:300,000 dilution for 
chemiluminescent detection. The anti-mouse IgG horseradish peroxidase-conjugated 
secondary antibody was supplied with the SuperSignal chemiluminescence kit (Pierce) 
and was used at a 1:5000 dilution.  Blots were developed using the chromogenic 
substrate 4-chloro-1-naphthol (Sigma) or with the West Femto SuperSignal 
chemiluminescence kit (Pierce). Chemiluminescent signal was detected using a Bio-Rad 
ChemiDoc XRS. 
 
Subcellular fractionation  
 Soluble or membrane localization was determined as described previously (133, 
159). Briefly, 25 mls of an induced culture were collected by centrifugation at 5,000 x g 
in a Sorvall Superspeed RC2-B centrifuge, and resuspended in 2 mls of French press 
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buffer (0.1 M sodium phosphate, 0.1 M KCl, 5 mM EDTA, 1 mM dithiothreitol, 1 mM 
phenylmethylsulfonyl fluoride, pH 7.0). Cells were disrupted by passage through a 
French pressure cell (Spectronic Instruments, Rochester, N.Y.) at 16,000 lb/in2.  The 
membrane and soluble fractions were separated by centrifugation at 100,000 x g in a 
Beckman TL-100 Ultracentrifuge for 60 min.  Equivalent amounts of each fraction were 
examined by SDS-PAGE and Western blotting as described above.  
 
Sulfhydryl modification using PEG-OPSS 
 To detect the presence of free cysteines in SAR endolysins, a 5 ml sample of a 
culture induced in logarithmic phase for 25 min was precipitated by TCA. The pellet was 
resuspended in 1 ml of PEGylation buffer (500 mM Tris pH 7.0, 1% SDS, 1 mM EDTA) 
and mPEG-OPSS (Nektar Transforming Therapeutics, Huntsville, Alabama) (84) was 
added to a final concentration of 3 μM.  The mixture was incubated for 30 min at room 
temperature and then precipitated by the addition of 1ml of ice-cold acetone.  The 
samples were held at –20°C for 10 min, after which the precipitate was collected by 
centrifugation at 18,000 x g at 4°C for 15 min. The pellets were air-dried, resuspended in 
non-reducing SDS sample buffer and examined by SDS-PAGE and western blotting. All 
samples were run with controls that had not been exposed to PEG-OPSS. 
 
Lyz103 expression and purification 
 Since wild type Lyz103 lyses cells rapidly when over-expressed, the enzyme 
activity was abolished by replacing the catalytic Asp with Asn. Hence, all purified 
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Lyz103 cited in this work refers to Lyz103D52N. pET lyz103D52N cHis was transformed into 
BL21 (DE3) cells (Invitrogen) harboring pLysS, and fresh transformants were cultured 
and induced for 1 hr at 30°C. Cells were collected at 4K RPM for 30 min at 4°C in a 
Sorvall RC-3B centrifuge and resuspended in Lyz103 buffer (20 mM Tris-HCl (pH 8), 
100 mM NaCl). Protease Inhibitor Cocktail for His-tagged protein (Sigma)) was added 
as per manufacturer’s instructions and cells were lysed by passage through a French 
pressure cell (Spectronic Instruments, Rochester, N.Y.) at 20,000 lb/in2. After removing 
unlysed cells and debris, the lysate was filtered through a 0.2 µm syringe filter. The 
cleared lysate was then applied to Talon Metal Affinity Resin (Clontech). Protein was 
eluted in elution buffer (20 mM Tris-HCl, 100 mM NaCl, 500 mM imidazole, pH 8), and 
was used with no further purification.   
 
CDAP cleavage 
 Purified Lyz103 D52N was precipitated and resuspended in 100 µl CDAP buffer 
(4M Guanidine-HCl, 0.1M Citrate, pH 3). 1-cyano-4-dimethylaminopyridinium 
tetrafluoroborate (CDAP, Sigma) prepared fresh in CDAP buffer, was added in 1,000-
fold molar excess and was incubated at room temperature for 15 min. NH4OH (EMD 
Chemicals) was added to 1M final concentration, and the mixture was incubated at room 
temperature for 3 hrs (97, 156).  Total protein was precipitated by addition of 1 ml of ice 
cold ethanol and incubation overnight at -20°C. Samples were pelleted, dried, and 
resuspended in sample loading buffer with or without 5% β-mercaptoethanol, as 
indicated. Equivalent amounts were analyzed by SDS-PAGE and western blotting. 
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Results and discussion 
 
The lysozyme from bacteriophage ERA103 has an N-terminal SAR domain   
We first wished to confirm that the N-terminal hydrophobic domain of Lyz103 is a 
SAR domain.  Inductions of lyz103 resulted in lysis of E. coli, even without a holin gene 
present, indicating a spontaneous release from the membrane and consequent lysis (Fig. 
2.2A). Moreover, like P1 Lyz, Lyz103 was found in both the soluble and membrane 
fractions of cells (Fig. 2.3A).  For both proteins, the membrane-associated and soluble 
forms migrate identically in SDS-PAGE, indicating the latter is not derived by 
proteolytic cleavage of the former.  Additionally, energy poisons such as DNP 
accelerated the lysis of cultures expressing lyz103 (Fig. 2.2A), indicating that collapse of 
the proton motive force facilitates the membrane release and activation of Lyz103, as it 
does for P1 Lyz (159).  The SAR domains characterized in P1 Lyz and R21differ from 
conventional TMDs in that they have a high content of weakly hydrophobic and 
uncharged polar residues such as Ala, Gly, and Ser .  In both cases, substitution of Leu 
residues for Gly residues (3 in P1 Lyz (Figs. 2.2, 2.3C); 2 in R21 (133)) in the SAR 
domain blocked release from the membrane and host lysis.  The same molecular and 
cellular phenotype was observed for Lyz103 when Gly residues at positions 9 and 10 in 
the SAR domain were converted to Leu (Figs. 2.2C, 2.3D).  These results are consistent 
with the requirement for the SAR domains to exit the membrane, liberating the thiol in 
the SAR domain to attack the inhibitory disulfide.  Thus Lyz103 is the third SAR 
endolysin to be characterized in terms of its physiological and topological 
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characteristics.  The predicted amino acid sequence of Lyz103 is identical to that of the 
lysozyme from bacteriophage φEa1h (69).  Thus, the puzzling lethality observed when 
lyzφEa1h was expressed in the absence of its holin (70) is due to the fact that, as a SAR 
endolysin, it reaches the periplasm by a holin-independent mechanism. 
 
The activity of Lyz103 is regulated by a disulfide “cage”  
Lyz103, like T4 E but unlike P1 Lyz, has an Asp as the middle residue of its 
catalytic triad, and thus is not regulated by covalent blocking of an active site Cys (Fig. 
2.1A).  Nonetheless, the N-terminal catalytic domain of Lyz103 contains three Cys 
residues (Cys12, Cys42, Cys45), including one in the SAR domain, suggesting that it 
might, like P1 Lyz, exist in two isomeric forms differing in the arrangement of 
intramolecular disulfide bonds .  To test this possibility, a C12S mutant of Lyz103 was 
tested for function.  This mutant was found to be lytically inactive (Fig. 2.2B), although 
it was released from the inner membrane as efficiently as the wild type protein (Fig. 
2.3B).  Moreover, addition of the reducing agent, dithiothreitol, to cells expressing the 
C12S mutant resulted in lysis (Fig. 2.2B).   
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FIG. 2.2. Lysis profiles of SAR endolysin derivatives. In each experiment, cultures 
of XL1 Blue containing P1 Lyz or Lyz103 in pJF118EH were induced at time 0. 
Optical density of the culture was followed as a function of time in mins. (A) 
Expression of Lyz103 lyses the cell independently of a holin. (○) P1 Lyz, (■) 
Lyz103, (□) Lyz103 + 10mM DNP (arrow) 20 mins after induction. . (B) Lysis by 
Lyz103 is dependent on the SAR domain Cys. (■) Lyz103 C12S, (□) Lyz103 C12S + 
1mM DTT at 36 mins (arrow) after induction, (♦) Lyz103 C12,42,45S. (C) P1 Lyz 
and Lyz103 can be locked into the membrane by Leu titration into the SAR domain. 
(○) Lyz103 G9, 10L, (■) P1 Lyz G8,9,10L. (D) P1 Lyz and Lyz103 can be 
interconverted. LyzP1→103 was achieved by two amino acid mutations: A41C and 
C51D (●). (○) LyzP1→103 C13S, (■) LyzP1→103 C13S + 1mM DTT at 45 min., 
Lyz103?P1 was achieved by two amino acid mutations: C42S and D52C (□), (♦) 
Lyz103?P1 C12S. (E) There is optimal positioning of the SAR domain Cys, Cys 
substitutions are labeled adjacent to their respective curves. (●) LyzP1→103 G9C, (■) 
LyzP1→103 G10C, (○ )LyzP1→103 A11C, (♦) LyzP1→103I12C, (Δ) LyzP1→103, (□) 
LyzP1→103A14C, (◊) LyzP1→103I15C, (▲) LyzP1→103 A16C. (F) The placement of 
the caging disulfide is stringent. (●) P1 Lyz I38C C51D, (○) P1 Lyz G39C C51D, 
(■) P1 Lyz N40C C51D, (□) P1 Lyz C13S I38C C51D, (♦) P1 Lyz C13S G39C 
C51D, (◊) P1 Lyz C13S N40C C51D. 
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Finally, the triple mutant, Lyz103C12, 42,45S, was found to be lytically active (Fig. 2.2B).  
The behavior of these two mutants is consistent with the model that nascent Lyz103 is 
inactive because of an inhibitory Cys42-Cys45 disulfide that is disrupted by Cys12 after 
the release of the SAR domain from the membrane.  Since the inhibitory disulfide 
predicted to exist in nascent Lyz103 involves cysteines that flank an essential catalytic 
residue (Fig. 2.1A), we refer to it as a “caging” disulfide, to distinguish it from the 
inactivating disulfide present in P1 Lyz.  It is of interest to note that a similar inactive, 
disulfide-caged form of T4 gpe was constructed 21 years ago (90).  In this form of T4 
gpe, the active site residues are unaltered, but an engineered disulfide occludes the active 
site.  As shown here with Lyz103 and earlier with P1 Lyz the disulfide-caged form of T4 
gpe could be activated by reducing agents.  
 
Disulfide bond isomerization 
 The results presented above indicate that the Cys42-Cys45 disulfide cages the 
catalytic Glu43 in inactive Lyz103 and that the Cys12 thiol from the SAR domain is 
required for activation, but do not reveal whether one of the two Cys residues flanking 
Glu43 participates in a disulfide exchange with Cys12 and, if so, which one (Fig. 2.1A). 
To address this question, we used the sulfhydryl cyanylation reagent 1-cyano-4-
dimethylaminopyridinium tetrafluoroborate (CDAP). 
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FIG. 2.3. Cellular locations of bacteriophages P1 and ERA103 SAR endolysins. 
For all panels, the total protein is represented by lane 1, the soluble protein 
fraction is represented by lane 2, and the membrane fraction is represented by 
lane 3. (A) Lyz103 exists in the soluble and membrane fractions of the cell. (B) 
Lyz103 C12S displays a non-lytic phenotype, but is released from the 
cytoplasmic membrane as efficiently as the wild type protein. (C) P1 Lyz can 
be confined to the inner membrane by replacing three Glycines (residues 8-10) 
with Leucine residues. (D) Lyz103 can be confined to the inner membrane by 
replacing two Glycines (residues 9 and 10) with Leucine residues. 
 
Treatment of a CDAP-cyanylated protein with a strong base cleaves the protein on the 
N-terminal side of the cyanylated Cys, leaving an N-terminal 2-iminothiazolidine-4-
carboxylyl (itz)-modification on the C-terminal product (97, 156).  If activated Lyz103 
has a disulfide between Cys12 and Cys42, Cys45 will be open for CDAP modification, and 
subsequent cleavage would create two polypeptide fragments which could be resolved 
from uncleaved protein without the presence of reducing agent (Fig. 2.4A).  In contrast, 
a linkage between Cys12 and Cys45 will leave Cys42 open for modification.  In this case, 
cleavage with strong base would result in polypeptide fragments that were still 
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covalently linked and which would require treatment with reducing agent to be resolved 
from uncleaved material (Fig. 2.4B). When purified Lyz103 was subjected to CDAP 
treatment and alkaline cleavage and analyzed by Western blot with anti-oligohistidine 
tag antibody, a polypeptide product of appropriate size (16 KDa) could be resolved from 
uncleaved protein (20 KDa) by SDS-PAGE without reducing agent (Fig. 2.4C).   The 
yield of cleavage product was low, approximately 10-15% of total protein.  However, 
treatment of the CDAP-modified product with PEG-OPSS revealed that >60% of the 
protein was cyanylated by CDAP and therefore unPEGylated (not shown), indicating 
that that the cleavage reaction, rather than sulfhydryl accessibility, was limiting, 
presumably due to the high incidence of the competing β-elimination reaction, as noted 
elsewhere (156). Taken together, these results indicate that the Lyz103 activating linkage 
resulting from the disulfide bond isomerization after SAR extraction is between Cys12 
and Cys42, rather than between Cys12 and Cys45, as predicted from the P1 Lyz and Lyz103 
sequence alignments (Fig. 2.1A). Thus, the position of the disulfide-bond exchange is 
not conserved.  
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FIG. 2.4. Analysis of the ‘cage’ relieving disulfide. Purified Lyz103 D52N cHis 
was subjected to CDAP cyanylation and alkaline cleavage. Proteins were 
resolved by SDS-PAGE with and without reducing agent, as indicated. (A) A 
cage relieving disulfide between Cys12 and Cys42 will allow Cys45 to be 
modified by CDAP. Cleavage of this protein results in a C-terminal cleavage 
fragment that is resolvable without addition of reducing agent (β-Me) (B) A 
cage relieving disulfide between Cys12 and Cys45 results in a cleavage product 
that is resolved only upon addition of β-Me. (C) Treatment of Lyz103 D52N 
with 1000 fold molar excess of CDAP reagent resulted in a resolvable C-
terminal cleavage product (16KDa) indicating the formation of a Cys12-Cys42 
disulfide.
 
 
The P1 Lyz and Lyz103 regulatory schemes are inter-convertible  
Comparing the crystal structures of the active and an inactive form of P1 Lyz 
demonstrates that much of the N-terminus of the protein is capable of adopting markedly 
different conformations depending upon the placement of a single intramolecular 
disulfide (158). To explore the structural malleability of the N-terminal catalytic domain 
of P1 Lyz (Glu42, Cys51, and Thr57), we attempted to convert P1 Lyz, in which the 
inactivating disulfide covalently blocks a catalytic Cys, into a Lyz103-type endolysin, 
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with a caging disulfide sequestering a catalytic Glu, by introducing the A41C and C51D 
mutations (Fig. 2.1B, Table 2.1).  This mutant, LyzP1→103, was found to be lytically 
active, although lysis was delayed and more gradual when compared with the wild type 
enzyme (Fig. 2.2D, Table 2.1).   As seen with P1 Lyz, removal of the SAR domain Cys 
in LyzP1→103 C13S rendered the enzyme dependent upon the addition of an exogenous 
reductant (Fig. 2.2D).   Moreover, introducing the C42S and D52C mutations into Lyz103 
(Fig. 2.1B) converted this enzyme into a P1 Lyz-type endolysin that still required the 
presence of the Cys residue in its SAR domain for lytic function (Fig. 2.2D).  Thus, with 
regard to the nature of inhibitory disulfide and the use of a catalytic Cys or Asp, P1 Lyz 
and Lyz103 are fully inter-convertible.  Since we had polyclonal antibodies at hand for P1 
Lyz which were much more efficient than the antibodies against the oligo-histidine tag 
for Lyz103, the LyzP1→103 construct was selected for further analysis. 
 
 
 
 
TABLE 2.1. Lyz103 mutant alleles. The catalytic triads, cysteines participating in 
enzyme regulation, mutations required for the LyzP1→103 and Lyz103?P1 conversions, 
and approximate lysis times of P1 Lyz, Lyz103, LyzP1→103, and Lyz103?P1 are listed. 
 P1 Lyz Lyz103 LyzP1→103 Lyz103?P1 
Catalytic triad E42, C51, T57 E43, D52, T58 E42, D51, T57 
E43, C52, 
T58 
Regulating 
cysteines 
C13 (SAR), C44, 
C51 (catalytic) 
C12 (SAR), 
C42, C44 
C13 (SAR), 
C41, C44 
C12 (SAR), 
C44, C52 
(catalytic) 
Conversion 
mutations 
 
n/a 
 
n/a 
 
A41C, C51D 
 
C42S, D52C 
Lysis time 
(min.) 15 35 50 45 
Cysteines located in the SAR domain and catalytic cysteines are indicated. 
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Optimal positioning of the SAR Cys residue  
 Since we had previously demonstrated that the in vivo activity of P1 Lyz 
depended upon the placement of the Cys13 residue in its SAR domain (158), we reasoned 
that the poor lytic profile obtained with the LyzP1→103 protein might be due to the 
suboptimal positioning of this critical residue.  To test this notion, constructs were 
generated in which the Cys13 residue in the SAR domain was moved to eight new 
positions, four in each direction, from the parental site in the context of LyzP1→103.  The 
results validated the hypothesis, in that earlier and sharper lysis profiles were obtained 
with a Cys occupying positions 12, 10, 14 and 16, in order of apparent lytic activity (Fig. 
2.2E).  This pattern is different from that observed using the equivalent substitutions in 
P1 Lyz, where the Cys13 form is the most active and moving the thiol to position 12 
eliminated the ability to activate (158).  These differences could be due to a combination 
of factors, since the activation of P1 Lyz involves major structural changes within the N-
terminal catalytic domain and all of the mutations necessary to convert P1 Lyz into 
LyzP1→103 and its derivatives occurred within this domain.   
 
Strict positional requirement for the inhibitory disulfide cage    
We next determined the effect of moving the position of the first Cys (Cys41) of 
the inhibitory disulfide cage in LyzP1→103 towards the N-terminus of the protein (Fig. 
2.1B).  All three variants (N40C, G39C, and I38C) tested were lytic (Fig. 2.2F).  
Surprisingly, the lethality of these proteins was not completely dependent upon the 
presence of a Cys in the SAR domain, as lysis still occurs, although much later and more 
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gradually (Fig. 2.2F).  The simplest explanation for this finding is that disulfides 
between Cys38, Cys39, or Cys40 and Cys44 do not effectively cage the active site 
glutamate.  We directly assessed the status of the cysteines in LyzP1→103, LyzP1→103 C13S, 
and P1 Lyz C13S, I38C, C51D, the most lytically active cage mutant, by testing their 
susceptibility to modification by PEG-OPSS. PEG-OPSS has a PEG 5000 moiety 
affixed to an orthopyridyl−disulfide. When reacted with a free sulfhydryl, PEG-OPSS 
will covalently bind, and will shift the apparent molecular weight of the protein (84). As 
expected, the active endolysin, LyzP1→103, was found to have a single free cysteine 
(Cys13) while the inactive enzyme, LyzP1→103C13S, had none (Fig. 2.5).  The lytically 
active P1 Lyz C13S, I38C, C51D protein was not modified with PEG-OPSS indicating that all 
six of its cysteine residues were present in disulfide linkages.  Thus, while the Cys38-
Cys44 disulfide forms, it is not inhibitory.   
 
 
 
 
 
FIG. 2.5. Assessment of the status of cysteine residues. Lane 1 contains 
molecular weight standards. P1 Lyz?103 is an active endolysin and has a single 
free sulfhydryl. It is modified by PEG-OPSS (Lane 2).  LyzP1→103 C13S has no 
free cysteine residues and is not modified by PEG-OPSS (Lane 3). LyzP1→103 
C13S, I38C, C51D is an active endolysin despite the presence of the caging 
disulfide. As confirmation of the presence of this disulfide, the protein is not 
modified by PEG-OPSS indicating that all of its cysteines are in disulfide bonds. 
Lanes 5-7 contain UnPEGylated LyzP1→103, LyzP1→103 C13S, and LyzP1→103  
C13S, I38C, respectively. 
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Conclusion  
 Two modes of SAR endolysin negative regulation have previously been 
experimentally established.   The first is that of an inactivating disulfide involving a 
catalytic Cys, as is present in P1 Lyz (158); the presence of the disulfide not only 
precludes participation of the catalytic Cys but also stabilizes a drastically misfolded N-
terminal domain. The second mode was found in R21, in which, although the inactive 
protein has more subtle folding defects, the active site is compromised by the proximity 
of the membrane to which it is tethered by the embedded SAR domain.  The results 
presented here demonstrate that Lyz103 represents a third distinct mode of SAR 
endolysin regulation:  disulfide-bond caging of the active site in the inactive form of the 
enzyme (Fig. 2.6).  Despite these differences in the regulatory mode, however, the two 
proteins appear to be completely interconvertible by simply repositioning the regulatory 
Cys residues and adjusting the position of the activating Cys residue in the SAR domain. 
These findings serve to emphasize both the plasticity of the SAR regulatory system and 
the importance of regulating the timing of lysis in the infection cycle.   
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FIG. 2.6. Model for Lyz103 activation. In its inactive form, Lyz103 is tethered to 
the charged cytoplasmic membrane. A caging disulfide exists between Cys42 
(blue) and Cys45 (green) that sequesters a catalytic Glu from the remaining 
members of the catalytic triad. Upon SAR domain (hatched bar) release from 
the membrane, the SAR thiol, Cys12 (red) attacks the caging disulfide at Cys42, 
forming a cage relieving disulfide. The catalytic Glu is released from the cage 
and can form the catalytic cleft.
 
 
Finally, it should be noted that another instance of disulfide-bonding affecting 
the steric blockage of an enzyme active site has been reported in NADP-malate 
dehydrogenase from chloroplasts (26).  In this case, intramolecular steric regulation is 
achieved when a C-terminal helix, positioned and stabilized by a disulfide bond, 
occupies the active site and forms hydrogen bonds with catalytic residues. The negative 
regulation is released when the conserved disulfide is reduced by thioredoxin in response 
to light stimulation.   A key difference is that the Lyz103 activation, driven by the release 
of the SAR domain from the bilayer, is almost certainly irreversible and thus the 
stabilities of the inactive and active states are unlikely to be comparable.  
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CHAPTER III 
REGULATION OF A MURALYTIC ENZYME BY DYNAMIC  
MEMBRANE TOPOLOGY  
Introduction  
It has been estimated that phage lysis events occur >1029 times a day and thus 
represent one of the major factors in the homeostasis of biomass (134). In general, lysis 
requires the enzymatic degradation of the host cell wall by a phage-encoded endolysin. 
For a successful infection, endolysin activity must be blocked throughout the latent 
period, typically 30 - 60 min, until, at lysis, there is a short period of acute enzymatic 
catalysis on the time scale of seconds (53). The canonical phage endolysins, like λ R, T4 
E, and T7 gp3.5, meet these requirements passively, in that they are synthesized as fully 
active enzymes but are restricted to the cytoplasm, where they have no substrate, until 
the instant when the phage-encoded holins trigger and open holes in the membrane (64, 
162). This robust regulation was thought to be universal until the discovery of 
endolysins with secretory signals (118, 159, 162).  Since secretory endolysins are not 
restricted from their substrate by the membrane, they require not only strict post-
secretory negative regulation but also the means to become activated in a timely manner.  
Phage-encoded holins control the timing of lysis by causing a temporally-regulated, 
saltatory disruption of the membrane but show no specificity for endolysins (53, 148, 
163). Thus the regulatory system of a secretory endolysin must depend on the integrity 
of the membrane, such that the loss of integrity causes quantitative activation of the 
muralytic function.  This requirement is met in SAR endolysins. 
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A SAR (Signal Anchor-Release) domain is an N-terminal transmembrane 
domain (TMD) that has the unique ability to exit the lipid bilayer completely (159). The 
first SAR domain was identified in P1 Lyz, the lysozyme of bacteriophage P1 and a 
homolog of the well-studied T4 lysozyme, protein E.  During the latent period, P1 Lyz is 
expressed and secreted to the periplasm, where it accumulates tethered to the membrane 
by the SAR domain. Premature destruction of the cell wall is avoided because in the 
membrane-tethered form, P1 Lyz is catalytically inactive, both conformationally and 
covalently.  In the inactive form (iP1 Lyz) , the N-terminal domain is in a radically 
different fold from the active enzyme (aP1 Lyz) and completely lacks its catalytic cleft.  
In addition, a catalytic Cys residue is occupied in a disulfide bond. Activation occurs via 
two dramatic transitions concomitant with the escape of the SAR domain from the 
bilayer (158, 159).  Covalent activation is achieved when a free thiol in the SAR domain 
causes a disulfide bond isomerization, releasing the catalytic cysteine.  In addition, the 
entire catalytic domain undergoes a large conformational reorganization, unwinding 3 α-
helices to form 3 β-strands in the active site. The extracted SAR domain itself 
contributes only the liberating thiol, remains largely helical, and makes no intimate 
contacts with the body of the enzyme. 
This elegant regulation, with its conformational and covalent levels, ensures that 
the phage morphogenesis period is not shortened by premature lysis.  However, many 
SAR endolysins do not have cysteine residues either in the transmembrane domain or the 
active site and thus must be regulated in a different way.  Here, we characterize one such 
enzyme, R21 (Fig. 3.1), the lysozyme of the lambdoid phage 21 (9, 20, 159), by genetic, 
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biochemical, and structural means.  R21 has the canonical Glu35-Asp44-Thr50 catalytic 
triad and a cysteine-free SAR domain which is not replaceable by that of P1 Lyz. The 
results are discussed in terms of unique phase-specific roles for the SAR domain in the 
inactive and active forms of the endolysin.  
 
Materials and methods 
 
Bacterial strains and growth conditions 
The Escherichia coli strains XL1-Blue and MG1655 ΔtonA lacIq have been 
previously described (127). To create MG1655 ΔtonA lacIq ΔlacY::Kan (RY16323), 
MG1655 ΔtonA lacIq (RY17307) was transduced to KanR with a P1 lysate grown on 
BW25113 ΔlacY::Kan (RY17459) using standard procedures (93). Standard conditions 
for the growth of cultures and the monitoring of lysis kinetics have been previously 
described (29, 127). When indicated, isopropyl-β-D-thiogalactopyranoside (IPTG) and 
chloroform (CHCl3) were added to final concentrations of 1 mM and 1%, respectively.  
Phase-contrast images were taken 100 minutes after induction using a Nikon Digital 
Sight DS-5M camera on a Nikon OPTIPHOT microscope. 
 
Standard DNA procedures  
Procedures for the isolation of plasmid DNA, DNA amplification by PCR, PCR 
product purification, DNA transformation and DNA sequencing have been previously 
described (52, 126, 128). Oligonucleotides were obtained from Integrated DNA 
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Technologies, Coralville, IA, and used without further purification. All enzymes were 
purchased from New England Biolabs, with the exception of Pfu polymerase which was 
from Stratagene. Site-directed mutagenesis was performed using the QuikChange kit 
(Stratagene). DNA sequencing was performed at the Laboratory for Plant Genome 
Technology of Texas A&M Agrilife.  
 
Plasmids  
To construct the plasmid pZE-R21, a derivative of the IPTG-inducible, medium-
copy vector pZE12 (86), the R21 gene was amplified from pJFR21 (159)  and cloned into 
pZE12.  The control plasmid pZE-luc (86) is pZE12 with a luciferase insert. An allele 
encoding R21 carrying the c-MYC tag (EQKLISEEDL) at the C-terminus was 
constructed using ExSite PCR (Stratagene).  To construct pZE12 with the chimeric allele 
encoding P1 Lyz1-26ΦR2127-165, the DNA encoding the SAR domain was amplified from 
pJFLyz (159) and the PCR product was then used as a mega-primer to replace the DNA 
encoding the R21 SAR domain.  Similarly, pZE12 derivatives carrying chimeric alleles 
(Fig. 3.1) encoding R21 with an artificial TMD (MK3L2I2V8I2L2) added at the N-terminus 
or with the PelB signal sequence replacing the residues 1-26 were constructed from 
pZER21 using ExSite PCR. The plasmids were designated pZE-TMDartΦR21 and pZE-
pelBssΦR2127-165, respectively.  The T7 over-expression plasmid pETR21 was constructed 
by amplifying the R21 gene from pBR121 (9) with primers that added DNA encoding the 
sequence GGHHHHHHGG at the C-terminus and inserting the product between the 
NdeI and BamHI sites of pET11a.  Similarly, to construct pETpelBΦ R2127-165, the DNA 
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encoding the truncated R2127-165 periplasmic domain was amplified and cloned into the 
NcoI and XhoI sites of pET22b (Novagen, San Diego, CA). 
 
Expression and protein purification 
For production of aR21, the plasmid pETR21 was transformed into Rosetta (DE3) 
pLysS (Novagen, Madison, WI).  Transformants were grown in Terrific Broth (BD, 
Franklin Lake, NJ) to A600 ~ 1 - 1.5 and induced with 0.5 mM IPTG. The culture was 
arrested between 60 to 90 minutes after induction, depending on the extent of lysis. The 
partially lysed culture was spun at 4000 rpm for 30 minutes at 4°C. Harvested cell 
pellets were stored at -20°C. The cells were resuspended in buffer (25 mM Tris-HCl (pH 
8.0), 500 mM NaCl, 3 mM β-Mercaptoethanol, 1% Triton X-100, and EDTA-free 
protease inhibitor cocktail (Roche Molecular)), and were disrupted by 2 passages 
through a French pressure cell at ~16,000 psi. After the lysate was centrifuged at 40,000 
rpm (Beckman Ti50.2) for 60 - 90 min, the supernatant was collected and applied to a 
5ml HiTrap-chelating Sepharose column (Amersham Pharmacia) connected in series, 
charged with NiCl2 and equilibrated with buffer A (25 mM Tris-HCl, pH 8.0, 500 mM 
NaCl, 2 mM β-mercaptoethanol and 10 mM imidazole). The column was washed with 
buffer A followed by increased concentration of imidazole (25 mM). Bound protein was 
eluted with a 25-500 mM imidazole gradient and the aR21 enriched fractions were 
pooled, concentrated, and dialyzed against a buffer containing 25 mM of sodium acetate 
pH 5.0, 25 mM NaCl and 1 mM DTT. All other contaminating proteins were 
precipitated upon dialysis with the minor fraction of aR21. Supernatant containing aR21 
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was concentrated and 50 µl aliquots were flash frozen in liquid nitrogen and stored at -
80 °C for further use. 
 For production of iR21, BL21(DE3) cells were transformed with pETpelBΦ R2127-
165 and grown at 37°C in LB medium containing 100 μg/ml of carbenicillin until A600 ~ 
0.8. The culture was induced with 0.5 mM IPTG and incubated for 18 h at 25 °C. iR21 
protein was purified through a Ni-affinity column and size-exclusion chromatography as 
described above. 
 
Crystallization and structure determination  
Purified aR21 at 20~30 mg/ml concentration was used to screen a large number of 
commercially available crystallization conditions by vapor diffusion method.  
Diffraction quality crystals of aR21 were obtained in a condition containing 150 mM 
sodium acetate pH 4.6 and 2 M sodium formate. iR21 was crystallized in the condition of 
100 mM Bis-Tris propane pH 7, 2.5M sodium nitrate. The best crystals grew in 2 weeks 
and were flash frozen in mother liquor with 20% glycerol then stored in liquid nitrogen. 
Data sets were collected in the lab (Rigaku MM007HF generator with Bruker Smart 
6000 CCD detector) and synchrotron beamlines at Advanced Photon Source (APS 23-ID 
and 19-ID), Argonne National Laboratory, Chicago. 
The initial structure was solved by single-wavelength dispersion using an iodine 
derivative obtained by quick soaking of the crystal in the cryo with 0.5M NaI for 
30~90s. Then the model was refined against the native dataset iteratively until the R/Rfree 
reached 0.212/0.249 at 1.95 Å for aR21 and 0.199/0.231 at 1.7 Å for iR21. The phasing 
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and refinement were carried out with the Phenix package (2). The models were built in 
Coot (39). PyMol (Delano Scientific; San Carlos CA) was used for structure analysis 
and rendering. 
 aR21 crystallizes in space group P212121 with unit cell dimensions of a = 78.2 Å, 
b = 94.8 Å, c = 97.7 Å, α = β = γ = 90° (Table 3.1) and four aR21 molecules in the 
asymmetric unit (ASU). All the residues can be traced in the electron density map. The 
first three molecules are nearly identical (backbone RMS = 0.4~0.5 Å). The fourth 
molecule in the ASU is the same as the other three except two loops, G27-S38 and 
T137-G146. iR21 crystallizes in space group P21212 with unit cell dimensions of a = 64.2 
Å, b = 109.7 Å, c = 45.0 Å, α = β = γ = 90° and two iR21 molecules in the ASU 
(backbone RMS =0.2 Ǻ). The first seven and last four residues are invisible in the 
structure. For both aR21 and iR21, the first molecule (chain A) in the asymmetric unit is 
used as the representative structure. 
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TABLE 3.1. Data collection and refinement statistics 
 full-length aR21  truncated iR2127-165 
Data collection1   
Space group P212121 P21212 
Cell dimensions 
a, b, c (Å) 78.2, 94.8, 97.7 64.2, 109.7, 45.0 
Wavelength (Å) 0.9795  0.9796  
Resolution (Å) 1.95 (2.05-1.95)  1.70 (1.79-1.70) 
I/sigI 19.3 (3.8) 23.9 (4.9) 
Completeness (%) 99.6 (99.2) 100 (99.8) 
Rsym 0.031 (0.268) 0.023 (0.213) 
Redundancy 7.2 (5.7) 6.1 (6.1) 
   
Refinement2   
# reflections 50721 35715 
Rwork/Rfree 0.2116/0.2485 0.1991/0.2311 
# atoms 5282 2483 
RMSD bonds 0.005 0.004 
RMSD angles 0.700 0.647 
1The R21 datasets were collected at AP 23ID and processed with HKL2000.  
2Refinement was done with Phenix.
 
 
Subcellular fractionation  
To determine whether a particular protein was present in the soluble or 
membrane fractions, 25 mls of an induced culture were collected by centrifugation at 
5000 x g and resuspended in 2 ml of buffer (0.1M sodium phosphate, 0.1M KCl, 5 mM 
EDTA, 1 mM dithiothreitol, 1 mM phenylmethylsulfonyl fluoride, pH 7.0) and then 
disrupted by passage through a French pressure cell (Spectronic Instruments, Rochester, 
N.Y.) at 16,000 lb/in2. The membrane and soluble fractions were separated by 
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centrifugation at 100,000 x g for 60 min. Equivalent amounts of the fractions were 
examined by SDS-PAGE and Western blotting as described below. To separate the 
periplasmic fraction, cells expressing pZER21 derivatives were collected after 30 minutes 
of induction by centrifugation at 5000 x g. Cells were resuspended in 0.5 ml of 
spheroplasting buffer (25% sucrose, 30 mM TrisHCl, pH 8).  Ten μl of 0.25 M EDTA, 
ten μl of lysozyme (20 mg/ml in water), and 500 μl of distilled water were added 
sequentially (24). The mixture was inverted several times and incubated for 5 minutes at 
room temperature.  Examination under the microscope showed that ~ 95% of the cells 
were spheroplasts. Spheroplasts were pelleted by centrifugation at 8,000 x g for 30 
minutes at 4 °C. Equivalent amounts of the supernatant (periplasm) and pellet 
(cytoplasm plus membrane) fractions were analyzed by SDS-PAGE and Western 
blotting as described below. 
 
SDS-PAGE and Western blotting  
SDS-PAGE, Western blotting, and immunodetection experiments were 
performed as previously described (52). A mouse monoclonal antibody against the c-
MYC tag was purchased from Covance and was used at a 1:1000 dilution. The anti-
mouse IgG horseradish peroxidase-conjugated secondary antibody was supplied with the 
SuperSignal chemiluminescence kit (Pierce) and was used at a 1:5000 dilution. Blots 
were developed using the West Femto SuperSignal chemiluminescence kit (Pierce). 
Chemiluminescent images were acquired using a Biorad ChemiDoc XRS. 
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Accession codes 
 The atomic coordinates and structure factors have been deposited in the PDB 
with the accession codes 3HDE and 3HDF for aR21 and iR21, respectively.  
 
Results  
 
The R21 class of SAR endolysins predominates in sequenced phage genomes 
 Prior to the discovery of SAR endolysins, all phage lysozymes that had been 
characterized, like T4 E, lambda R, and T7 gp3.5, were found to be soluble enzymes that 
accumulate fully folded and enzymatically active in the cytoplasm (64, 162). Thus 
degradation of the cell wall, and subsequent lysis, could be controlled by maintaining the 
integrity of the membrane until it was permeabilized at the appropriate time by the 
phage-encoded holin.  However, when we surveyed 196 sequenced phage genomes, we 
found 58 endolysin genes with the Glu-8aa-Asp/Cys-5aa-Thr catalytic triad (Fig. 3.1) 
that characterizes the canonical T4 E, a true lysozyme.  Unexpectedly, most (43/58) have 
N-terminal hydrophobic domains with the characteristics of SAR domains (Table 3.2); 
i.e., predicted N-terminal transmembrane α-helices which have a higher representation 
of Gly, Ala, and Ser residues compared to typical transmembrane domains (TMDs).  
Thus SAR-type endolysin regulation is the rule, rather than the exception, at least among 
the T4 E homologs of sequenced phage genomes. Moreover, among these 43 SAR 
endolysins, only nine have a Cys residue within the SAR domain and a catalytic cysteine 
as observed in P1 Lyz and Lyz103 (74, 158, 159). This suggests that, at least among the 
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sequenced genomes of phages known to be viable, the disulfide bond-dependent 
regulation of P1 Lyz is the exception rather than the rule, and that the remaining 34 SAR 
enzymes must be regulated differently. One of these enzymes, R21, has already been 
confirmed as a SAR endolysin (159), and was chosen for detailed study.  
 
 
 
TABLE 3.2. SAR endolysins dominate the true lysozyme proteins. 
endolysin subtype # phage genomes characterized enzymes3 
   
cytoplasmic 15 T4 E, P22 gp19 
SAR with Cys  9 P1 Lyz 
SAR without Cys 34 R21 
   
total 58  
Endolysin subtype was defined by existence of predicted TMDs or SAR domains at 
N-terminus. Absence of both resulted in scoring as cytoplasmic. 196 phages of 
Gram-negative hosts were analyzed from the Phage category of the GenBank 
Genome database. Characterized enzymes are those which have been purified and 
characterized by biochemical or structural methods.
 
 
The SAR domain of R21 is essential for its lysozyme activity  
Previously, we demonstrated that the SAR domain of P1 Lyz is not an essential 
component of the structure or the enzymatic activity of the protein.  In other words, the 
SAR domain is used only to regulate by tethering the protein to the membrane and, after 
release from the bilayer, to supply a cysteine for activation of the enzyme (158). To 
determine whether this was also true for R21, we replaced the N-terminal 26 residues of 
R21 with the cleavable secretory signal sequence PelBss (76) (Fig. 3.1). When the 
pelBssΦR2127-165 chimera was expressed in Escherichia coli, no significant cell lysis was 
observed (Fig. 3.2A) even though large amounts of the processed R2127-165 protein 
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accumulated in the periplasm (Fig. 3.2B). Moreover, an in vitro lysozyme assay of the 
purified protein did not detect lysozyme activity (data not shown). The lack of in vivo 
and in vitro activity of the truncated R21 indicated that the SAR domain of R21 is 
necessary for its enzymatic function. 
 
 
 
 
FIG. 3.1. N-terminal sequences of R21, P1 Lyz, and T4 E. The N-terminal domains of 
R21, P1 Lyz and T4 E are shown aligned by the E-8aa-(D/C)-5aa-T catalytic triad.  
SAR domains are boxed in orange. Leu substitutions made in R21 are shown above 
Gly14 and Gly15. The PelB signal sequence (PelBss; yellow) and the artificial TMD 
(TMDart; yellow) are shown with arrows indicating points of fusion in the chimeric 
constructs. In the N-terminal domain, catalytic triad residues are in blue. Residues 
involved in positioning the catalytic glutamate are highlighted by a light blue box in 
P1 Lyz and T4 E.   
 
 
Further, when Gly14 and Gly15 of the SAR domain were replaced with Leu 
residues (Fig. 3.1), the R21 SAR domain lost its ability to escape the membrane (Fig. 
3.2E) and lysis was blocked unless CHCl3 was added to disrupt the bilayer (Fig. 3.2A, 
F).  On the other hand, appending an artificial TMD to the N-terminus of full-length R21 
resulted in a chimera that was membrane-tethered (Fig. 3.2C) and, although not 
 62
explicitly lytic (Fig. 3.2A), had sufficient enzymatic activity to convert all the induced 
cells to spherical morphology (Fig. 3.2G). Apparently, in this chimera, the location of 
the R21 SAR sequence distal to the TMD prevented its recognition by the sec system and 
caused it to be secreted into the periplasm with the rest of the polypeptide. Moreover, 
replacing the SAR domain of R21 with that of P1 Lyz resulted in a chimera that, although 
retaining the ability to be released from the membrane (Fig. 3.2D), was inactive (Fig. 
3.2A).  In contrast, P1 Lyz is still functional when its SAR domain is replaced by that of 
R21 (158). Taken together, these results demonstrate that, besides controlling the 
topology of protein, the SAR domain in R21 plays a specific and more integral role in the 
catalytic activity of enzyme, compared to that in P1 Lyz.  
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FIG. 3.2. Induction of R21 and derivative alleles. (A) Lysis profiles. (○) pZE-luc, 
(●) pZE-R21G14,15L, (□) pZE-luc + 1mM CHCl3 at 80 minutes after induction, (■) 
pZE-R21G14,15L + 1mM CHCl3 at 80 minutes after induction, (◊) pZE-R21, (♦)P1 
Lyz 1-26ΦR2127-165, (Δ) pZE-pelBssΦR2127-165, (▲) pZE-TMDartΦR21. (B-E) 
Localization and processing of R21 and derivatives after induction of the indicated 
plasmids. For panels b and c, lane 1 = total, lane 2 = periplasm, and lane 3 = 
spheroplast fraction. For panels d and e, lanes 1, 2, and 3 represent the total, 
soluble, and membrane fractions, respectively. (b) pZEpelBΦR2127-165, (c) pZE-
TMDartΦR21, (d) P1 Lyz1-26ΦR2127-165, (e) pZE-R21G14,15L. (F-H): Morphologies of 
cells carrying indicated R21 plasmids at 100 minutes after induction. (f) pZE-
R21G14,15L, (g) pZE-TMDartΦR21 (h) pZE12-luc.
 
 
The structural basis of R21 regulation  
 To explore the structural basis for this novel regulation, the crystal structures of 
the active, full-length enzyme, aR21, and the inactive enzyme, iR21, which is missing the 
entire SAR domain, were solved to high resolution by Quingan Sun in the lab of Dr. Jim 
Sacchettini at Texas A&M University (Table 3.1). aR21 shares the characteristic 
dumbbell structure of the canonical T4 lysozyme, with the 42 residues distal to the SAR 
sequence forming a relatively independent catalytic domain, containing a catalytic triad 
(Glu35, Asp44 and Thr50) connected by a long, domain spanning α-helix (Lys68 to 
Tyr89) to the bundle of C-terminal α-helices (helix α4 to α8) (Fig. 3.3A, C).  Despite 
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marginal sequence identities (33.9% of R21 with P1 Lyz, 30.3% with P22 gp19, 18.8% 
with T4 E), these 3D structure elements are conserved in all of the known structures of 
T4 E-like lysozymes (R21, P1 Lyz, P22 gp19, and T4 E) and the geometry of the 
catalytic triad in aR21 (Glu35, Asp44, and Thr50) is nearly identical to those of the other 
three (Fig. 3.3B) (10, 96, 158).  
In the structures of T4 E (Fig. 3.3C) and P1 Lyz (Fig. 3.3D), an α-helix from the 
N-terminal of the protein (Ile3 - Glu11 in E; Asn31 – Gly43 in P1 Lyz) interacts 
extensively with the C-terminal lobe and serves to position the essential glutamate in the 
active site as part of the catalytic triad. In P1 Lyz, this stabilizing helix is 12 residues in 
length and separated from the SAR domain by a turn (NVRT) (158). Residues 14-26 of 
the SAR helix in aP1 Lyz assume an α-helical conformation that packs lateral to the 
stabilizing α-helix. However, in aR21, the SAR domain is folded into two anti-parallel α-
helices, α1 (residues Pro3 to Gly15) and α2 (residues Ala17 to Thr26), connected by a 
sharp turn consisting of triple Glycines 14-16. These two helices pack against the C-
terminal helical bundle (α4 – α8) at an angle of about 45º (Fig. 3.3A). Importantly, 
inspection of the predicted electrostatic surfaces reveals that the interface between the 
SAR domain and the body of the enzyme is dominated by hydrophobic contacts. The 
critical Glu of aR21 (Glu35) is located not on the helix itself, but on a loop directly 
downstream of the SAR helix. This loop is stabilized by a network of hydrogen bonds 
which includes residues of the SAR domain. The catalytic Glu35 appears to be further 
stabilized by the salt bridge between its Oε and the side chain of Arg152 from helix α8 
of the C-terminal helical bundle, a feature well-known for T4 E (131) and also shared by 
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the P22 and P1 enzymes.  Sequence alignment of R21-like endolysins indicates that this 
Glu-Arg salt bridge is fully conserved in this family (Fig. 3.4).  
Additional differences were observed in the structure of the R21 inactive form 
(iR21) compared to the active enzyme (Fig. 3.5). Although overall the iR21 crystal 
diffracted to higher resolution than that of aR21 (Table 3.1), the five N-terminal residues 
preceding Asn31 were not visible in the electron density map. The catalytic Glu35 can 
be only built to Cβ, presumably due to the flexibility of this region in the inactive form.  
Whereas in P1 Lyz, the active and inactive forms have radically different structures, the 
overall fold of iR21 is nearly identical to that of aR21, with every major secondary 
structural element preserved, except the changes to the active site, described below. Like 
P1 Lyz, R21 has two disulfide bonds that provide structural stability, but unlike P1 Lyz, 
there is no difference in the disulfide bonding pattern between the active and inactive 
forms.  In the catalytic domains of aR21 and iR21, the loop regions between Ser38 and 
Thr67, which includes two of the residues of the catalytic triad, Asp44 and Thr50, are 
superimposable (rmsd ~0.361 Å). However, the absence of the two α-helices of the SAR 
domain and the adjacent H-bond network has a dramatic effect on the position of the 
Glu35, which is displaced about 10Å.  Its position in the active enzyme is occupied by 
Lys147 in iR21, in the loop connecting two of the C-terminal helices, α7 and α8.  Lys147 
is likely to further ensure that the active site in iR21 would not be capable of binding 
substrate and concomitantly fold into active geometry.  Given the indispensable role of 
the catalytic Glu demonstrated in T4 E (117), the displacement and disorder of Glu35 
account for the lack of enzymatic activity in iR21. 
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FIG. 3.3. Structural comparison of aR21 and T4 E. (A) Overall structure of aR21. The 
cartoon is colored according to secondary structure (helix in cyan, sheet in 
magenta, coil in brown), while the SAR helices (α1 and α2) are in orange. The 
catalytic triad and the two pairs of disulfide bonds are shown as stick structures (Q. 
Sun, Texas A&M University). (B) The catalytic triad (Glu35, Asp44 and Thr50). 
The catalytic loop regions of T4 E (Glu11-Thr59, grey C-α trace), P1 Lyz (Glu42-
Lys72, green C-α trace) and P22 gp19 (Glu16-Ile50, yellow C-α trace) were 
superimposed on aR21 (Glu35 - Thr67); the RMSs are 0.66Ǻ, 1.03Ǻ and 0.40 Ǻ, 
respectively. The catalytic triads of T4E, P1 Lyz, and P22 gp19 are shown in stick. 
The 2Fo-Fc electron density map of aR21 around the triad is shown at the 1.0 σ 
level. (C) The structure of T4 E. The cartoon is colored as described for Fig 3a. The 
helix responsible for placement of the catalytic Glu is shown in blue. Catalytic 
residues are shown in stick. Residues involved in the hydrophobic interaction 
between the Glu placing helix and the C-terminal bundle are shown in grey stick. 
(D) The structure of aP1 Lyz. The cartoon is colored as described for Fig 3A. As in 
3c, the helix responsible for placement of the catalytic Glu is shown in blue with 
hydrophobic interaction residues in grey stick. Disulfide bonds are represented in 
yellow stick, and Cys residues participating in the activating disulfide bond 
isomerization (Cys13 and Cys44) are labeled. 
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FIG. 3.4. The Glu-Arg salt bridge is fully conserved in the R21-like endolysin family. 
Salt bridge residues are highlighted in green. Only the salt bridge region is shown. 
The catalytic glutamate residue forms a salt bridge (blue bracket, top) with an Arg in 
helix 8. Catalytic (arrow), fully conserved (*), and nearly completely conserved 
residues (dot) are indicated. The labels of the aligned sequences correspond to the 
following Genbank records: LKD16: gi|158345072, LUZ19: gi|167600491, 
phiKMV: gi|33300856, phi1026b: gi|38707914, phi644-2: gi|134288680, Bcep176: 
gi|77864683, BcepB1A: gi|48697551, RTP: gi|81343992, T1: gi|45686348, TLS: 
gi|148734541, JK06: gi|71834140, PY54: gi|33770570, R21: gi|215468, Phagectd I: 
gi|148609440, phiEco32: gi|167583572, ST104: gi|46358689, 933W: gi|9632511, 
Stx2-convI: gi|20065952, Stx2-conv86: gi|116221999, N15: gi|3192716, BP-4795: 
gi|157166033, Mu: gi|6010396. 
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FIG. 3.5. Topological and conformational dynamics of R21 activation. Color 
scheme as in Fig. 3.3.  On the left, the SAR domain is shown as a membrane-
spanning helix in the inactive, membrane-tethered form.   
 
 
Discussion  
 
A new mechanism for the regulation of SAR endolysins  
 Mechanistic insight for the regulation of secretory endolysins became available 
only recently, for the SAR endolysin of coliphage P1 (158, 159). After sec-mediated 
export, P1 Lyz is tethered to the membrane by its N-terminal SAR domain and 
maintained in an inactive state by virtue of a disulfide bond between the catalytic Cys51 
and a second Cys residue (Cys44) in the catalytic domain, as well as by the complete 
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disorganization of its N-terminal catalytic domain.  The SAR domain escapes from the 
membrane, at a low constitutive rate or quantitatively and synchronously when the holin 
triggers to disrupt the membrane.  In the active, soluble form of P1 Lyz, a Cys residue in 
the SAR domain replaces the catalytic Cys in the disulfide bond, and the N-terminal 
catalytic domain is completely refolded, yielding a properly-arranged catalytic triad 
straddling the substrate-binding cleft (Fig. 3.3D) (158). In this active structure, the SAR 
domain makes no significant contacts with the body of the enzyme other than the 
disulfide linkage.  In fact, except for the disulfide linkage, the SAR domain of P1 Lyz is 
not essential for the function of the endolysin. Even the position of the Cys residue 
within the SAR domain is very flexible, suggesting that the SAR domain can be 
arranged in a variety of orientations with respect to the catalytic domain (158).  The 
studies presented here describe an entirely different mode of regulation for the SAR 
endolysin of phage 21, the prototype of a class of SAR endolysins much more frequently 
represented in annotated phage genomes than the P1 Lyz class (Table 3.2). Although 
aR21 shares both its overall structure and the geometry of its catalytic triad and substrate-
binding cleft with P1 Lyz and with T4 E (Fig. 3.3), there is a fundamental difference. In 
aR21, the SAR domain, when removed from the membrane where it is presumably 
entirely helical, "jack-knifes" into a helix-turn-helix structure that makes many intimate 
contacts with the N-terminal catalytic domain and the C-terminal helical bundle and is 
essential to the activity of the enzyme.  Moreover, the overall structure of the N-terminal 
catalytic domain is much more preserved between the iR21and aR21 structures, in 
comparison to the dramatically different folds of iP1 Lyz and aP1 Lyz. Only a loop 
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segment of the catalytic domain adjacent to the SAR sequence is arranged differently, 
with the Glu residue of the catalytic triad averted from the enzymatic cleft in iR21.  
Another striking contrast is that activation of R21involves significant reorientation and 
restructuring of the C-terminal helical bundle, resulting in the formation of a 
hydrophobic binding site for the helix-turn-helix structure of the released SAR domain.  
In iP1 Lyz and aP1 Lyz, the C-terminal domains are very similar (158). Overall, the 
structural transitions are much less dramatic in R21 activation than for P1 Lyz. Thus, 
paradoxically, after extraction from the membrane the SAR domain of R21 enters the 
structure of the enzyme intimately without causing fundamental restructuring. In 
contrast, the extracted SAR domain of P1 Lyz provides only its thiol group for covalent 
activation of the catalytic triad and can do so in a number of orientations, yet activation 
of P1 Lyz is associated with a complete refolding of the entire N-terminal catalytic 
domain and de novo creation of the substrate-binding cleft. The simplest notion is that 
the periplasmic domain of iP1 Lyz is much less stable. Upon insertion into the 
membrane, P1 Lyz is remodeled by the host DsbA (159), and may be conformationally 
remodeled by host chaperones after release. For R21, the small but distinct differences 
between the conformations of the bundled C-terminal helices, especially helices α4 and 
α8, suggest a possible induced fit mechanism for its activation.  Once the SAR domain 
has escaped from the membrane, the simplest way to minimize the exposure of its most 
hydrophobic residues is to pack against the non-polar face of helix α4, which could lead 
to dislodgement of helix α8 and further conformational adjustments.  In this perspective, 
the newly released SAR domain activates R21 through the spatially adjacent C-terminal 
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helical bundle, rather than the sequence-close N-terminal domain. 
 
Comparison of the two strategies 
 The regulatory strategies adopted by P1 Lyz and R21 have significant differences. 
iP1 Lyz has two levels of negative control: covalent inactivation of its active site Cys 
and a N-terminal catalytic domain with radical conformational disability. In contrast, iR21 
appears to lack only the correct placement of its catalytic Glu, which is sterically 
blocked from attaining its position by a hydrogen-bonded lysine side-chain.  These 
striking differences suggest evolutionary trade-offs exacted to meet the conflicting dual 
responsibilities of the SAR endolysin: maintenance of an inactive state throughout the 
infection cycle and also the ability to effect degradation of the murein as rapidly as 
possible, once the holin has triggered and depolarized the membrane.  Moreover, in 
contrast to canonical endolysins, which are completely blocked from premature 
muralytic function by sequestration in the cytoplasmic compartment, SAR endolysins 
are inherently leaky, in the sense that even without holin function, enzymes are 
constitutively released from the membrane, thus becoming activated during the latent 
period (109).  P1 Lyz appears to be better suited for negative control in view of the Cys 
substitution for Asp in the catalytic triad, which has been shown to reduce enzyme 
activity in the T4 E context (58). R21 seems to be more poised for muralytic function, 
with its canonical catalytic triad and the minimally dysfunctional conformation of the 
inactive enzyme.  The particular evolutionary path taken by these two SAR endolysins 
would reflect the selective pressures exerted on the lysis process.  In particular, analyses 
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based on the Minimum Value Theorem for predator-prey relationships have indicated 
that conditions of sparse host availability and/or poor growth conditions favor extended 
infection cycles and thus favoring an endolysin less prone to premature activation (147). 
In contrast, target-rich and/or rapid growth environments favor shorter infection cycles 
and more rapid release of the progeny virions, which would favor the more efficient and 
muralytic endolysin.  
 
Dynamic membrane topology of the SAR domain 
 Compared to canonical transmembrane domains, SAR domains are enriched in 
Gly and Ala residues, a feature that is critical for dynamic membrane topology. In R21, 
replacement of two Gly residues with Leu eliminates the ability of the SAR endolysin to 
escape from the membrane (Fig. 3.2E).  Nevertheless, SAR domains still have numerous 
hydrophobic residues which, after extraction from the lipidic milieu, are a liability in the 
aqueous environment of the periplasm. In R21, the cluster of Gly residues in the SAR 
domain provides a second structural function, serving as the hinge allowing the extracted 
SAR domain to fold into two shorter helices. Besides creating a new helix-helix 
interface to accommodate hydrophobic residues, this also compacts the SAR domain 
sufficiently that it can fit into a hydrophobic pocket on the surface of the main body of 
the enzyme. Consequently, nearly all the hydrophobic residues of the SAR domain are 
buried in the active structure, and the most solvent-exposed surface is populated by 
hydrophilic residues. 
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 Is R21 representative of the Cys-less SAR endolysins in terms of the structure and 
role of the SAR domain in the active enzyme?  A compilation of the N-terminal 
sequences including the SAR domains and the catalytic triads of 22 Cys-less SAR 
endolysins suggests that there may be several different modes (Fig. 3.6), since the SAR 
domain varies significantly in its proximity to the active site Glu.  R21 shares similar 
SAR domain arrangements with endolysins from phages encoding potent human toxins, 
including the cytolethal distending toxin (6), CDT, and the Shiga toxin (113); moreover, 
in the latter case, the acute dispersal of the toxin in the mammalian gut is dependent on 
the muralytic action of the SAR endolysin (101, 103).  In no case does the hydrophobic 
core of the SAR domain extend farther than 3 - 4 helical turns without encountering a 
Gly or Pro residue.  These residues are tolerated in helices in the membrane but are 
helix-breakers in aqueous solvent (77), suggesting that in most or all of these proteins, 
the SAR domain uses some version of the R21 strategy of converting the SAR sequence 
into a helix-turn-helix packed against the main body of the enzyme to solve the problem 
of what to do with a transmembrane domain out of its native lipidic environment. In 
some homologs, the SAR domain immediately abuts the catalytic Glu residue; in these 
enzymes, most of the SAR domain must constitute the stabilizing helix. Taken together 
with the structures described here, it seems clear that SAR domains represent structural 
elements of unparalleled evolutionary flexibility, both in terms of membrane topology 
and the capacity for integration as a regulatory component.  
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FIG. 3.6. Alignments of unique SAR endolysins lacking Cys residues in their SAR 
domains.  The N-terminal SAR and catalytic domains of R21-like SAR endolysins are 
shown aligned by the catalytic triad (yellow).  These sequences were selected from 
the 34 sequences identified in Table 3.2 by the criterion of having at least one amino 
acid residue difference in the complete sequence. Completely conserved (asterisk) 
and nearly completely conserved (dot) residues are indicated.  SAR domains are 
indicated in green, along with helix-breaking residues Gly (blue) and Pro (purple).  
The Genbank records correspond to those used in figure 3.4. 
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CHAPTER IV 
THE PREVALENCE OF SAR ENDOLYSINS AMONG dsDNA 
PHAGES OF GRAM-NEGATIVE HOSTS 
Introduction 
 The classic lysis paradigm for the lysis of Gram-negative hosts by dsDNA 
phages is typified by phage lambda. It consists of three components: a cytoplasmic 
endolysin; an inner membrane (IM) channel-forming protein, the holin; and the spanin 
complex, consisting of an integral IM protein and an outer membrane (OM) lipoprotein 
(163).  A three-step model has been proposed for the coordinated lytic function of these 
proteins.  At the end of the vegetative cycle, the holin forms large, non-specific lesions 
in the IM that allows passage of the muralytic endolysin. Consequently, the 
peptidoglycan (PG) is compromised, triggering the action of the spanin complex. 
Endolysins in this paradigm include homologs of phage T7 gp3.5 (an amidase), lambda 
R (a transglycosylase), T4 E (a lysozyme), and T5 Lys (a peptidase). The lysozymes and 
transglycosylases belong to the lysozyme-like superfamily and share a common fold and 
the amidases belong to the peptidoglycan recognition protein (PGRP) superfamily. 
Amidases cleave the amide bond between MurNAc and L-alanine, transglycosylases and 
lysozymes cleave the β-1,4 glycosidic linkages between MurNAc and GlcNAc moieties, 
and peptidases cleave the peptide bonds between amino acids of the tetrapeptide 
crosslinks of the PG (Fig. 1.2). 
Recent work has uncovered a new lysis paradigm. Rather than a cytoplasmic 
endolysin, this new paradigm depends on a secreted SAR (Signal Anchor Release) 
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endolysin (159). A SAR endolysin contains an N-terminal transmembrane domain 
(TMD), the SAR domain, which, compared to normal TMDs, is richer in weakly 
hydrophobic or polar residues such as Ala, Gly, and Ser. SAR endolysins are secreted by 
the SecYEG translocon and accumulate in the periplasm tethered to the energized IM . 
The SAR domain is so named because it first acts as a membrane anchor but has the 
capacity to escape from the membrane. The release of the SAR domain occurs 
spontaneously at a low rate but occurs quantitatively when the holin triggers to 
depolarize the membrane.  Some SAR endolysins are coupled with pinholins, a class of 
holins that form small lesions (109). The pinholin depletes the proton motive force 
(PMF) of the IM, causing the immediate release of the tethered SAR endolysin. Similar 
to the lambda paradigm, this system also contains a spanin complex for OM disruption. 
To date, several SAR endolysins including P1 Lyz, R21, Lyz103, and N4 gp61 have been 
experimentally characterized (74, 130, 133, 158).  
SAR endolysins are expressed from the beginning of the late gene expression 
period, along with all the morphogenesis proteins. To prevent premature lysis of the host 
cell, it is imperative to block the PG degrading activity (133). The first SAR endolysin to 
be genetically and structurally characterized was P1 Lyz from phage P1 (158). It is a 
homolog of T4 E and contains an E-8x-C-5x-T catalytic triad. In its membrane-tethered 
form, the protein is maintained in a covalently inactivated state, in that the catalytic Cys 
in position 51 is held in a disulfide bond. This inhibition is relieved when the SAR 
domain is released from the membrane. A sulfhydryl in the SAR domain attacks the 
inactivating disulfide, releasing Cys51, freeing the catalytic thiol and allowing refolding 
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of the catalytic domain (158). Lyz103, the SAR endolysin of Erwinia amylovora phage 
ERA103, is also regulated by a disulfide bond isomerization. Rather than using an 
inactivating disulfide, Lyz103 is regulated by means of disulfide caging of a catalytic 
residue (74). Most SAR endolysins, however, do not contain Cys residues in their SAR 
domains, and thus cannot be regulated by disulfide bond isomerization (133). These 
proteins are also T4 homologs and have the canonical E-8x-D-5x-T catalytic triad. The 
prototype of this class of SAR endolysins is R21 from lambdoid phage 21. The inactive 
form of R21 was shown to have a misfolded catalytic cleft, mainly in that the catalytic 
Glu residue is displaced by 10 angstroms. Upon release from the membrane, the SAR 
domain associates with the C-terminal domain to position the catalytic Glu, thus forming 
the active site. Bioinformatic analysis suggests that this latter regulatory mechanism is 
most predominant among SAR endolysins, based on the sequenced phage genomes.  
Here we undertake a comprehensive bioinformatic search for endolysins of 
phages of Gram-negative hosts. The goals of this study are to determine the extent of 
endolysin variety in regards to classes/mechanisms, to discern any new lysis paradigms, 
and to determine the prevalence of the SAR endolysin paradigm among phages of Gram-
negative hosts. The results are discussed in terms of evolution of phage lysis and of the 
topologically dynamic SAR endolysin.  
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Materials and methods 
 
Bioinformatic endolysin identification and phyolgenetics 
Our search for endolysin genes encompassed the annotated dsDNA phages of 
Gram-negative bacteria listed in the NCBI Entrez Genome and Nucleotide databases to 
date. Sequence similarity searches were carried out against the non-redundant protein 
sequences database using NCBI BLASTp (3). Initial rounds of identification were 
performed using a single query sequence: T7 gp3.5, T4 E, lambda R, and T5 Lys 
representing the amidase, glycosidases, transglycosylase, and endopeptidase classes, 
respectively. Subsequent rounds of identification were performed using the lowest 
scoring (E-value), non-redundant sequences from these searches. This method was 
repeated until no additional endolysin hits could be identified. Endolysins not identified 
using this method were found by hand either by verifying proteins annotated by the 
submitters as endolysins or by manual BLASTp and PSI-BLAST searches. Manual 
searches utilized the NCBI Conserved Domain Database (CDD). Conserved domain 
searches were performed for protein coding sequences between 100 and 200 amino acids 
proximal to the phage structural genes. Any remaining phage genomes were submitted to 
EMBL-EBI InterProScan (114) as FASTA files for functional domain prediction. 
Phylogenetic tree analysis was performed using Phylogeny.fr, a free online suite that 
performs multiple sequence alignments using MUSCLE, phylogenetic tree construction 
with PhyML, and tree rendering with TreeDyn (35). Unrooted trees are presented due to 
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the difficulty in selecting an outgroup among organisms that are known to transfer genes 
among each other frequently (36). 
 
Bacterial strains and growth conditions   
 The Escherichia coli strains BL21 (DE3) pLysS, XL1-Blue, MC4100, and 
MG1655 ΔtonA lacY- lacIq have been described (127, 133). Standard conditions for the 
growth of cultures and the monitoring of lysis kinetics have been previously described 
(29, 127).  All bacterial cultures were grown in standard LB medium, supplemented with 
100 μg/ml ampicillin when appropriate. When indicated, isopropyl β-D-
thiogalactopyranoside (IPTG) and dinitrophenol (DNP) were added to final 
concentrations of 1 mM and 10 mM, respectively.   
 
DNA procedures and plasmid construction   
 Procedures for the isolation of plasmid DNA, DNA amplification by PCR, PCR 
product purification, DNA transformation, site-directed mutagenesis, and DNA 
sequencing have been previously described (52, 126, 128). The plasmid 
pZEBcep22gp79, a derivative of the medium copy, IPTG-inducible vector pZE12 (86), 
was constructed by PCR amplifying Bcep22 gp79 from the genome and inserting it 
between the KpnI and XbaI sites of pZE12 digested with the same enzymes. Derivative 
alleles were constructed using site-directed mutagenesis. The construct pETΦV10gp29 
was constructed by PCR amplifying ΦV10 gp29 from the genome (kindly provided by 
Bruce Applegate) and inserting it between the NdeI and BamHI sites of pET11a. For 
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detection and purification purposes, Bcep22gp79 and ΦV10gp29 were modified by 
ExSite PCR to encode an oligohistidine tag (Gly2His6Gly2) appended to Gln174 and 
Val209, respectively.  All purified protein cited in this work refers to the oligohistidine-
tagged versions. 
 
Subcellular fractionation  
 Soluble or membrane localization was determined as described previously (133). 
Briefly, 25 mls of an induced culture were collected by centrifugation at 5,000 x g in a 
Sorvall Superspeed RC2-B centrifuge, and resuspended in 2mls of French press buffer 
(0.1M sodium phosphate, 0.1M KCl, 5 mM EDTA, 1 mM dithiothreitol, 1 mM 
phenylmethylsulfonyl fluoride, pH 7.0). Cells were disrupted by passage through a 
French pressure cell (Spectronic Instruments, Rochester, N.Y.) at 16,000 lb/in2.  The 
membrane and soluble fractions were separated by centrifugation at 100,000 x g in a 
Beckman TL-100 Ultracentrifuge for 60 min. To separate the periplasmic fraction, cells 
expressing pZER21 derivatives were collected after 30 min of induction by centrifugation 
at 5000 x g. Cells were resuspended in 0.5 ml of spheroplasting buffer (25% sucrose, 30 
mM TrisHCl, pH 8).  Ten μl of 0.25 M EDTA, 10 μl of lysozyme (20 mg/ml in water), 
and 500 μl of distilled water were added sequentially (24). The mixture was inverted 
several times and incubated for 5 minutes at room temperature.  Examination under the 
microscope showed that ~ 95% of the cells were spheroplasts. Spheroplasts were 
pelleted by centrifugation at 8,000 x g for 30 min at 4 °C. Equivalent amounts of each 
fraction were examined by SDS-PAGE and Western blotting as described below.  
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SDS-PAGE and Western blotting   
 SDS-PAGE, Western blotting, and immunodetection experiments were 
performed as previously described (52). A mouse monoclonal antibody against the 
oligo-histidine epitope tag was purchased from Amersham and was used at a dilution of 
1:3000. The anti-mouse IgG horseradish peroxidase-conjugated secondary antibody was 
supplied with the SuperSignal chemiluminescence kit (Pierce) and was used at a 1:5000 
dilution.  Blots were developed using the West Femto SuperSignal chemiluminescence 
kit (Pierce). Chemiluminescent signal was detected using a Bio-Rad ChemiDoc XRS. 
 
Protein expression and purification 
 pETphiV10gp29cHis was transformed into BL21 (DE3) cells (Invitrogen) 
harboring pLysS, and fresh transformants were cultured and induced for 3 hrs at 30°C. 
Cells were collected at 4K RPM for 30 min at 4°C in a Sorvall RC-3B centrifuge and 
resuspended in purification buffer (50 mM NaH2PO4, 300 mM NaCl, pH 8). Protease 
Inhibitor Cocktail for His-tagged protein (Sigma) was added as per manufacturer’s 
instructions and cells were lysed by passage through a French pressure cell (Spectronic 
Instruments, Rochester, N.Y.) at 20,000 lb/in2. After removing unlysed cells and debris, 
the lysate was filtered through a 0.2 µm syringe filter. The cleared lysate was then 
applied to Talon Metal Affinity Resin (Clontech). Protein was eluted in elution buffer 
(50 mM NaH2PO4, 300 mM NaCl, pH 5).  
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Lysozyme activity assay 
Peptidoglycan degradation activity was determined by turbidometry using 
resuspended Micrococcus lysodeikticus cells. Briefly, various quantities of the specified 
purified protein were added to micro-plate wells. Lyophilized M. lysodeikticus cells were 
resuspended in reaction buffer (50 mM sodium acetate, pH 6.5) at a concentration of 
1mg cells/mL. 100 μL cells were added to each well and the optical density was read at 
A550 in a Tecan Infinite M200 Pro in 2 min time points for 1 hr.  
 
Results 
 
Identification of phage endolysin genes  
A bioinformatic search for endolysins from dsDNA phage infecting Gram-
negative hosts was undertaken. 279 Genbank dsDNA phage entries were searched, and 
their respective endolysins were identified (Table 4.1). Phages of archaea and 
cyanobacteria were excluded from the search as these phages have lysis systems that are 
beyond the scope of this review. Our treatment also excluded Gram-positive phage 
endolysins, since they tend to be modular in architecture and can have more than one 
catalytic domain (163). Our search was limited to sequenced phage genomes as these 
were acquired by DNA isolated from phage particles released presumably by functional 
endolysins, hence prophage were excluded.    
 The identified endolysins fall into four superfamilies (Table 4.1). The 
superfamilies group based on structural homology, i.e. members of the lysozyme-like 
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superfamily share a similar “classic lysozyme” fold. The superfamilies differ in PG bond 
specificity: lysozyme-like superfamily members cleave the β-1,4-glycosidic bond, 
amidase superfamily members cleave the amide bond between MurNAc and L-Ala, and 
members of the Hedgehog/DD-peptidase superfamily cleave the peptide bonds between 
peptide crosslinks. The lysozyme-like superfamily is further broken down into sub-
classes based on catalytic mechanism, i.e. lysozymes, chitinases, transglycosylases, etc. 
The muraminidase mechanism has been inferred by catalytic residues as described 
below. One class of endolysins could only be identified by its PG binding domain. These 
proteins compose their own PG_binding_1 superfamily. Few phages contained no 
identifiable endolysin candidate. 
 
Lysozymes 
The members of the most dominant endolysin class (32% of total) are homologs 
of the muraminidase T4 E, a true lysozyme (73). In the past, the term lysozyme has been 
used loosely to describe PG degrading enzymes (47). For example, T7 gp3.5 (30) , 
lambda R (14), goose egg white lysozyme (GEWL) (140), and the endolysin of phage 
T5 (34) have been described as lysozymes despite their more accurate classifications of 
gp3.5 as an amidase, R and GEWL as a transglycosylases, and the T5 endolysin as a 
peptidase. Here, we will use the term as it applies to T4 E, the original lysozyme and its 
homologs. 
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TABLE 4.1. Endolysin candidates from dsDNA phages of Gram-negative hosts. 
SuperfamilyA Endolysin Sub-classB 
Percent 
of 
TotalC 
MembersD 
Lysozyme-
like 
Superfamily 
Lysozyme 32 
21, 25, 31, 65, 2851,44RR2.8t, 933W, 
Acj61, Aeh1, APSE-1, AR1, Bcep176, 
BcepB1A, CC31, Cd, cdtI, D108, 
ERA103, ES18, F108, Felix01, Fels-2, 
HP1, HP2, IME08, IME09, JK06, 
JS10, JS98, K139, kappa, KP34, 
LKA1, LKD16, LUZ19, Min27, Mu, 
N15, P1, P7, P22, PA11, PAJU2, PaP3, 
phi1026b, phi-2, phi4795, phi644-2, 
phiAS4, phiAS5, phiEA100, 
phiEA104, phiEA1H, phiEa21-4, 
phiEco32, phiHISC, phikF77, 
phiKMV, phiMHaA1, phi-O153, 
phiPLPE, phiSG1, phiSG3, PT2, PT5, 
PX29, PY54, RB14, RB32, RB51, 
RB69, RE-2010, RTP, SE1, SP18, 
ST104, Stx-conv I, Stx2-conv 171, 
Stx2-conv 86, Stx2-conv I, Stx2-conv 
II, T1, T4, T4T, TLS, vB_EcoM-VR7, 
VT2-Sakai, WV8, Xfas53, YYZ-2008 
 
TransglycosylaseE
 
13 
186, B3, BcepC6B, BcepMu, 
BcepNazgul, c341, CP220, Cpt10, D3, 
DE3, E1, Eco1230-10, EL, epsilon34, 
g341c, HK022, HK620, HK97, KP15, 
KS10, L-413C, lambda, M6, P2, 
phiE255, phiKZ, phiO18P, phiSboM-
AG3, PsP3, RM378, rv5, SC1, SC2, 
Sf6, SfV, WPhi, YuA 
Glycoside 
hydrolase family 
19 chitinase 
 
8 
11b, 14-1, 16-3, Aaphi23, AB1,  
BcepF1, epsilon15, F8, F10, Fels-1, 
JG024, LBL3, LMA2, OP2, PB1, 
phiAB1, phiV10, phiW-14, 
RSL1,S1249, SN, ST64B 
Glycoside 
hydrolase family 
24 
 
 
8 
133, Bcep22, BcepIL02, F116, Gifsy-
1, Gifsy-2 K1G, K1H, K1ind1, K1ind2, 
K1ind3, KPP10, KS7, LIMElight, 
LUZ24, OP1, phiL7, RSB1, SETP3, 
So-1, SS3e, SSL-2009a, Xop411, Xp10
DUF 847 
superfamily 3 
BIP-1, BMP-1, BPP-1, N4 
(enterobacteria), phiHAP-1, VHML, 
VP58.5, VP882 
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TABLE 4.1. Continued 
SuperfamilyA Endolysin Sub-classB 
Percent 
of 
TotalC 
MembersD 
N-acetyl 
muramoyl-L-
alanine 
amidase-like 
superfamily 
Amidase 12 
13a, 285P, Ac42, Acj9, BA3, BA14, 
Berlin, DSS3phi2, EcoDS1, 
EE36phi1, gh-1, ICP3, 
ICP3_2007_A, ICP3_2008_A, 
ICP3_2009_B, K11, K1F, KP32, 
Kvp1, MmP1, VchoN4, PBC5, phi15, 
phiA1122, phiIBB-PF7A, phiSG-JL2, 
phiYeO3-12, SIO1, T3, T7, Vi06, 
VP4, Yepe2, Yep-phi 
Hedgehog/DD
-peptidase 
superfamily 
Carboxypeptidase 11 
119X, B40-8, EcP1, EPS7, H105/1, 
IN93, JSE, K1-5, K1E, KS9, KVP40, 
Mx8, PA73, PaP2, Phi1, phiEcom-GJ, 
phiJL001, phiKO2, phiP27, RB16, 
RB43, RB49, SP6, SPC35, ST160, 
ST64T, T5, VP2, VP5, VP93, Xp15 
PG_binding_1 
superfamily 
 
Pfam01471 
 
8 
203phi2-1, Bcep1, Bcep43, Bcep781, 
BcepNY3, KL3, KS14, KS5, L17, 
PAK_P1, phi52237, phiCTX, phiE12-
2, phiE202, phiRSA1, PR4, PR5, 
PR772, PRD1, S1, Vi01 
n/a No candidate 5 
BcepGomr, D3112, DMS3, LIT1, 
LUZ7, MP22, MP29, MP38, P4, 
PA1/KOR/2010, PM2, VpV262 
SAR endolysins are in bold. 
A Endolysin superfamily determined by BLAST sequence homology. 
B Endolysin type determined by conserved domains and homologs found during 
BLAST searches using experimentally verified proteins of each type. 
C Percent of 279 total genomes analyzed 
D Phage names are as listed in the Viral Genome Resource at NCBI 
[http://www.ncbi.nlm.nih.gov/genomes/VIRUSES/35237.html]. All phages are 
Caudovirales except for phages L17, PR3, PR4, PR5, PR772, and PRD1, which are 
members of Tectiviridae. 
E Phages in italics are members of the GEWL family of transglycosylases (see text). 
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In general, muraminidases cleave the β-1,4 linkages between MurNAc and GlcNAc 
residues. Members of the lysozyme class were characterized by their E-5x-D/C-8x-T 
catalytic triad, where the center position can be either an Asp or a Cys with little penalty 
to activity (58). Lysozymes are bi-lobal with a catalytic N-terminal domain and an α-
helical C-terminal domain connected by a long inter-domain helix. Upon further 
inspection of the T4 homologs, it was found that a majority of them (52 of 90 or 57% of 
lysozymes in the survey) contain an N-terminal hydrophobic extension that is not 
present in E (Table 4.2). This extension is characterized as being 16-22 amino acids in 
length and has a high proportion of weakly hydrophobic and non-charged polar residues 
such as Ala, Gly, Ser, and Thr. The sequences were analyzed for transmembrane 
propensity using TMHMM. If the above criteria were met, the corresponding stretch of 
amino acids was designated as a SAR domain and the endolysins were classified as SAR 
endolysins. The putative SAR endolysins were further classified based on the presence 
or absence of a Cys in the SAR domain. Those that contain a SAR domain Cys were 
presumed to be disulfide bond regulated (DSB) and those without were designated as 
R21-like.  
 
Glycoside hydrolase family 24 
Twenty-three out of 279 phage endolysins were identified as belonging to the 
endolysin/autolysin super-family. The endolysin/autolysin enzymes are predicted to have 
a general muraminidase function. Members of this class include a variety of PG 
degrading enzymes such as T4 E, lambda R, chitinases, and bacterial autolysins involved 
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in cell wall turn-over. To gather more information regarding possible mechanism, 
members of our endolysin/autolysin group were queried in CAZY, the Carbohydrate 
Active enZYmes database. All of the members of our endolysin/autolysin group belong 
to the glycoside hydrolase family 24 (GH24). GH24 proteins are predicted by UniProt to 
use a catalytic Glu to protonate the glycosidic bond in a hydrolase mechanism similar to 
lysozymes. Inspection of the GH24 sequences showed no canonical lysozyme-like 
catalytic triad, so these proteins were not classified as true T4 E homologs. In our search, 
almost half (43%) of these enzymes contained putative SAR domains and were 
classified as “GH24” SAR endolysins.   
 
Transglycosylases 
The second largest category of endolysins (13%) identified were the lytic 
transglycosylases (LTs). Like T4 E, LTs are muraminidases as they cleave β - 1,4 
linkages between MurNAc and GlcNAc residues, however, they use a different 
mechanism. The LTs identified fell into two sub-categories: those related to R, the LT of 
phage lambda (55% of LTs) and those that are related to goose egg white lysozyme 
(GEWL) and bacterial soluble lytic transglycosylases (SLT) (45% of LTs). Goose type 
and phage LTs represent families 1 and 4, respectively, according to a transglycosylase 
compilation which identified four families based on sequence similarity and conserved 
domains (15). 
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TABLE 4.2. Putative SAR endolysins.  
Phage Phage accessionA Host Endolysin entry TypeB 
21 215466 Enterobacteria 67436 R21 like 
2851 209407371 Enterobacteria 209407416 R21 like 
933W 9632466 Enterobacteria 9632511 R21 like 
Bcep176 77864625 Burkholderia 77864683 R21 like 
Bcep22 158997720 Burkholderia 158997736 GH24 
BcepB1A 68165913 Burkholderia 48697551 R21 like 
BcepIL02 238801616 238801690 Burkholderia GH24 
BcepMu 48696910 Burkholderia 48696932 LT 
cdtI 148609382 Escherichia coli 148609440 R21 like 
CP220 294337971 Campylobacter 294338091 LT 
CPt10 294338166 Campylobacter 294338289 LT 
D108 281199644 Escherichia coli 281199665 R21 like 
Era103 125999960 Erwinia 126000009 DSB 
F108 73918060 Pasteurella 109302925 DSB 
F116 48527494 Pseudomonas 56692926 GH24 
Fels-2 169936017 Enterobacteria 169936041 DSB 
HP1 9628600 Haemophilus 9628630 DSB 
HP2 13752188 Haemophilus 17981840 DSB 
JK06 71834082 Enterobacteria 71834140 R21 like 
K139 17975105 Vibrio 17975138 DSB 
kappa 165292211 Vibrio 165970268 DSB 
KP15 294661423 Klebsiella 294661543 LT 
KP34 294661411 Klebsiella 282554633 R21 like 
KPP10 297591648 Pseudomonas 297591686 GH24 
KS10 197725423 Burkholderia 198449271 LT 
LIMElight 308071837 Pantoea 308071892 GH24 
LKA1 114796430 Pseudomonas 158345187 R21 like 
LKD16 114796377 Pseudomonas 158345072 R21 like 
LUZ19 161168305 Pseudomonas 167600491 R21 like 
M6 89155211 Pseudomonas 149408252 LT 
Min27 163955703 Enterobacteria 170783656 R21 like 
Mu 9633494 Enterobacteria 6010396 R21 like 
N15 9630464 Enterobacteria 3192716 R21 like 
N4 117650898 Enterobacteria 119952230 DUF847 
OP1 84662593 Xanthomonas 84570669 GH24 
P1 46401626 Enterobacteria 33338666 DSB 
P7 33323506 Enterobacteria 33323523 DSB 
phi1026b 38707890 Burkholderia 38707914 R21 like 
phi-2 281306659 Pseudomonas 281306699 R21 like 
phi4795 31044225 enterobacteria 31044270 R21 like 
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TABLE 4.2. Continued 
Phage Phage accessionA Host Endolysin entry TypeB 
134288680 R21 like phi644-2 148734199 Burkholderia 
phiE255 134288788 Burkholderia 134288836 LT 
phiEA100 311875322 Erwinia 311875369 DSB 
phiEa1H 311875202 Erwinia 311875248 DSB 
phikF77 225626323 Pseudomonas 225626372 R21 like 
phiKMV 33300811 Pseudomonas 33300856 R21 like 
phiL7 238695587 Xanthomonas 238695615 GH24 
phiMHaA1 90110542 Mannheimia 109289945 DSB 
32170989 R21 like phi-O153 56682761 Escherichia coli 
phiPLPE 195964712 Iodobacteriophage 197085629 R21 like 
PT2 165880710 Pseudomonas 195546752 R21 like 
PT5 158187602 Pseudomonas 195546690 R21 like 
PY54 33770508 Yersinia 33770570 R21 like 
RE-2010 312601701 Salmonella 312601724 DSB 
RSB1 197935896 Ralstonia 197935896 GH24 
RTP 81343928 Enterobacteria 81343992 R21 like 
SE1 219681191 Salmonella 219681236 R21 like 
ST104 46358648 Enterobacteria 46358689 R21 like 
Stx1-conv I 32170834 Escherichia coli 32170989 R21 like 
Stx2-conv 86 115500802 Escherichia coli 116221999 R21 like 
Stx2-conv 1717 209447126 Escherichia coli 209447172 R21 like 
Stx2-conv I 20065797 Escherichia coli 20065952 R21 like 
Stx2-conv II 32171002 Escherichia coli 32171161 R21 like 
T1 45686283 Enterobacteria 45686348 R21 like 
TLS 38046731 Enterobacteria 148734541 R21 like 
VT2-Sakai 9633396 Enterobacteria 9633441 R21 like 
Xfas53 273810419 Xylella 273810445 R21 like 
Xop411 148727181 Xanthomonas 148727205 GH24 
Xp10 32128412 Xanthomonas 32128440 GH24 
162135144 YuA 162135082 Pseudomonas LT 
YYZ-2008 209427726 Enterobacteria 209427769 R21 like 
 SAR endolysins were identified in the genomes of 71 phages of Gram-
negative hosts  
A The GenBank identifier numbers for the phage and endolysin are given. 
B The type of SAR endolysin was determined by manual inspection. T4 E 
homologs with no Cys in the SAR domain were designated as R21 like. The E 
homologs with a Cys in the SAR domain were presumed to be regulated by 
disulfide bond isomerization (DSB). Members of the glycoside hydrolase 
family 24 were deemed ‘GH24’ SAR endolysins. Candidates that are GEWL 
homologs are designated as SAR containing lytic transglycosylases (LT). The 
SAR endolysin of phage N4 is categorized as a DUF847 protein (130).  
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Three of the families identified in that study were bacterial and the fourth contained 
transglycosylases similar to lambda R. Interestingly, the bacterial SLT/GEWL proteins 
have a lysozyme fold (described above) (139). In our study, members of these categories 
were classified based on conserved domains as described by Blackburn and Clarke (15). 
Of the two families identified here, only the family 1 LTs (SLT/GEWL homologs) were 
found to have putative SAR domains and were classified as “LT” SAR endolysins 
(Table 4.2). 
 
Chitinases 
Twenty-two phages were found to encode an endolysin containing a COG3179 
domain that has the predicted function of a chitinase. More specifically, members of this 
class are members of the glycoside hydrolase family 19. Chitin is composed of repeating 
units of GlcNAc, which is the main component in fungal cell walls and is also found in 
the exoskeletons of insects, crustaceans, and other invertebrates. Chitinases hydrolyze 
the β-1,4-glycosidic linkages between GlcNAc residues using a single-replacement 
reaction that results in inversion of the PG  sugar configuration at C1 (55). Chitinases 
belonging to the family 19 have two catalytic Glu residues positioned eight residues 
apart. These two catalytic residues and their spacing are conserved among the putative 
members of this family found in our search. Divergence from a common ancestor has 
been suggested between chitinases and lysozymes based on structural similarities (95). 
Despite the lack of sequence similarity, both enzymes contain N and C-terminal lobes, 
are highly alpha helical, and have a large catalytic cleft.  
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DUF847 superfamily 
Eight phages were found to have endolysins belonging to the DUF847 
superfamily. A notable entry of this type is gp61 from the enterobacteria phage N4. 
Gp61 has been characterized as an N-acetylmuramidase by mass spectrometric detection 
of reduced muropeptide fragments after hydrolysis (130). Although it is not a true T4 E 
homolog, it is presumed to use a hydrolase mechanism (described in detail below). 
Interestingly, when gp61 was cloned and expressed in Escherichia coli cells, rapid lysis 
occurred independently of a holin. Fractionation showed that the protein was found in 
the IM and the periplasm at the same apparent molecular mass. These characteristics 
suggest that N4 gp61 is a SAR endolysin. Other members of this family contain a 
catalytic Glu (E26 in gp61), which is shared with other N-acetylmuramidases like T4 E, 
but do not have a predicted SAR domain. 
 
Amidases 
Thirty-four out of 279 phages encoded putative amidases. Mutational analysis of the T7 
amidase, gp3.5, has shown that residues Tyr46 and Lys128 are responsible for amidase 
activity and residues His17, His122, and Cys130 are important for Zn2+ binding, required 
for amidase function (30). All of the putative amidases identified in this search contained 
the Tyr and Lys catalytic residue equivalents and a predicted metal binding site. Twenty-
eight of the 34 amidase containing phages are T7-like podophages. Silicibacter phage 
DSS3phi2 and Sulfitobacter phage EE36phi1 are N4-like podophages. Interestingly, the 
Acinetobacter phages Ac42 and Acj9 are T4-like myophages.  
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Peptidases 
Eleven percent of the endolysins were identified as peptidases. These are usually 
metallopeptidases that use zinc or some other divalent cation as a cofactor. Peptidases 
cleave the peptide bonds between the amino acids of the PG tetrapeptide crosslinks. The 
lytic peptidases similar to the phage T5 peptidase are specific for the L-alanoyl-D-
glutamate peptide bond. Members of the peptidase class were identified by the canonical 
catalytic motif of H-6x-D-Xx-D-2x-H where the H-6x-D motif represents the metal 
binding site and the final D-2x-H (separated from the metal binding site by a variable 
amino acid region) is the active site (19). The peptidase containing phages are a mix of 
sipho, myo, and podophages. 
 
PG binding domains 
Eight percent of the endolysins were identified by their peptidoglycan binding 
domain (pfam01471). This domain contains a helix bundle that is found in several PG 
degrading enzymes including the endolysins from Pseudomonas aeruginosa 
bacteriophages ΦKZ and EL (23). The proteins in this category have the DGX-Pho-
GXXT consensus sequence, where Pho represents a hydrophobic amino acid (49). The 
tectiviruses (L17, PR4, PR5, PRD1, and PR772) and pseudomonas phage PAK_P1 
contain DUF3380 domains that are usually associated with PG binding domains. Other 
than that association, no additional information is available for these domains. Sequence 
analysis by PSI-iBLAST provides no additional information regarding possible 
mechanism or catalytic residues of the proteins in this category. 
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No candidate 
Five percent of the phages searched contained no bioinformatically identifiable 
endolysin candidate. Phages in this category were manually inspected for gene 
annotation and ORFs were checked for homology to known lysis proteins. Furthermore, 
phage genomes were submitted to InterPro Scan analysis (164). No identifiable 
endolysin hits were recovered. Of the 12 phages with no identifiable candidate, 8 are 
Pseudomonas phages. The genomes of phage with no endolysin candidate were acquired 
by sequencing DNA from phage preps indicated that phage particles had been released 
in some way (4, 27, 56, 57, 60, 88, 165). Interestingly, some of the phages (BcepGomr, 
D3112, and DMS3) have identifiable holin and spanin candidates, but no muralytic 
enzyme. Perhaps these phages contain a novel endolysin class that has yet to be 
characterized.  
 
Distribution of SAR endolysins 
 Overall, the SAR endolysins were found to compose 25% of the endolysins 
identified. Within the SAR endolysins, 75% are homologous to T4 gpe and are true 
lysozymes. Fourteen percent are GH24 proteins and 11 percent are transglycosylases. 
The SAR endolysin of enterobacteria phage N4 belongs to the DUF847 family (130). 
Interestingly, these four protein types are all members of the Lysozyme-like superfamily. 
They share motifs of the classic lysozyme fold including a catalytic Glu and cleave the 
β-1,4-glycosylidic linkage between MurNAc and GlcNAc moieties. For the most part, 
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their amino acid sequences are unrelated, but they are hypothesized to share a common 
ancestor (62, 75, 95). 
 
Bcep22 gp79 is a SAR endolysin, experimental confirmation 
Of the 23 proteins in the GH24 category, 10 contained putative SAR domains. 
The putative SAR endolysin from Burkholderia phage Bcep22 was selected as a 
representative of this group for further analysis. Since a SAR endolysin can 
spontaneously release from the membrane, it can lyse cells independently of holin 
expression. Accordingly, when pZEgp79 was expressed, overt culture lysis occurred 
(Fig. 4.1A). In the context of a phage infection, however, SAR endolysins are released 
synchronously by the depolarizing action of the holin. Energy poisons such as 
dinitrophenol (DNP) mimic the effect of the holin and cause premature release from the 
membrane and thus early lysis, as is the case here (Fig. 4.1A). A subcellular 
fractionation revealed that the protein was present in both the soluble and membrane 
fractions of the cell. The apparent molecular mass of the released and bound protein was 
the same indicating that the latter was not a proteolysed version of the former (Fig 4.1B). 
As with previously studied SAR endolysins (74, 133), the protein could be restricted to 
the membrane by replacement of adjacent Gly or Ala residues with Leu residues, with 
either two or three substitutions required, depending on the SAR endolysin.  In this case, 
the replacement of two Ala residues converted gp79 to a membrane-bound protein and 
also eliminated its lytic function (Fig 4.1A, C). SAR endolysins are secreted through the 
Sec translocon (159) and their secretion through the translocon can be prevented by the 
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SecA inhibitor, azide (105). Accordingly, azide blocks spontaneous lysis by gp79 (Fig. 
4.1A). Taken together, these results unambiguously categorize Bcep22 gp79 as a SAR 
endolysin. 
 
 
 
 
FIG. 4.1. Bcep22 gp79 is a SAR endolysin. In each experiment, cultures of MG1655 
containing pBcep22gp79 were induced at time 0. Optical density of the culture was 
followed as a function of time in mins. (A) Expression of Bcep22 gp79 lyses the cell 
independently of a holin. (●) wt, (■) Bcep22gp79 2A2L, (♦) wt + 10mM DNP added 
at 50 min. after induction, (▲) wt + NaN3 at time 0, (▼) Bcep22gp79 E26Q. For (B-
D), the total protein is represented by lane 1, the soluble protein fraction is 
represented by lane 2, and the membrane fraction is represented by lane 3. (B) 
Bcep22 gp79 is in the soluble and membrane fractions of the cell. (C) Bcep22 gp79 
can be confined to the inner membrane by replacing two Glycines (residues 16 and 
17) with Leucine residues. (D) Bcep22 gp79 E26Q is non-lytic, but is still released 
from the membrane as efficiently as wt. 
 
 
Bcep22 gp79 represents a new class of SAR endolysins 
As mentioned above, members of the GH24 family are thought to hydrolyze the 
MurNAc-GlcNAc glycosidic linkage like true lysozymes. These proteins, however, do 
not contain the T4 E-like E-5x-D/C-8x-T catalytic triad and are not true T4 E homologs. 
As a member of the GH24 family, Bcep22 gp79 may constitute a new class of SAR 
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endolysins. Since all previously identified SAR endolysins are homologs of T4 gpe, and 
GH24 proteins are putative hydrolases, we wanted to know how the GH24 proteins were 
related to lysozymes. We were also interested in determining the relationship between 
SAR lysozymes and SAR GH24 proteins. Phylogenetic tree analysis was performed on 
the lysozyme and GH24 protein sequences (113 total sequences). Overall, the GH24 
proteins (Fig. 4.2, purple (soluble GH24) and green (SAR GH24)) do not group together 
in a single clade. Instead, they share clades, mostly with SAR lysozymes. The base of 
the tree is unclear making it difficult to determine early evolutionary relationships; 
however, some conclusions can be drawn from the branches. Feature 1 highlights a clade 
containing a GH24 SAR protein from the Panteoa phage LIMElight and an R21-like 
SAR lysozyme from Klebsiella phage KP34. Since both of these proteins contain a SAR 
domain, we could hypothesize that perhaps these proteins diverged from a common 
ancestor that was a SAR endolysin. It may even be that in this case, the SAR domain 
predates the functional split (GH24 vs. lysozyme) between the two proteins. Another 
interesting relationship is shown in feature 2 between P1 Lyz-like SAR lysozymes from 
Vibrio phages K139 and kappa, and the R21-like SAR lysozyme of Xylella phage Xfas53. 
A similar relationship is seen in feature 5 between the SAR lysozymes of Enterobacteria 
phages T1, Fels-2, and RE-2010. In both features, the P1 Lyz-like and R21-like SAR 
lysozymes share a branch point indicating that they may share a common SAR domain 
containing ancestor, perhaps indicating that the SAR domain was acquired before the 
development of the regulation style. Feature 3 points out a clade containing soluble 
GH24 proteins from Salmonella phages Gifsy-1 and Gifsy-2 among soluble lysozymes 
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from Soldalis phages phiSG1 and phiSG3 and a Acyrthosiphon pisum (Pea aphid) 
secondary endosymbiont phage APSE-1 (43). What is unique about these lysozymes is 
that rather than using an E-8x-D-5x-T catalytic triad like the other soluble lysozymes, 
these proteins use an E-8x-C-5x-T triad similar to P1 Lyz. These proteins could 
represent the missing link between SAR endolysins and soluble lysozymes (discussed in 
more detail below).  A more defined relationship between the Gifsy-1 and Gifsy-2 
proteins and the lysozymes is difficult to pinpoint due to a polytomy (a node with more 
than two branches) in the tree. A polytomy can indicate a speciation event but most often 
indicates a lack of genetic information and an inability to define phylogeny (48). Feature 
5 shows another relationship between disulfide bond regulated SAR endolysins and R21-
like SAR endolysins. As stated previously, all R21-like proteins identified to date use the 
canonical E-8x-D-5x-T catalytic triad. Of the disulfide bond regulated SAR endolysins, 
the SAR endolysins of Erwinia phages Era103 (74), phiEa100, and phiEa1H (70) are the 
only proteins to use the canonical triad as opposed to the P1 Lyz-like E-8x-C-5x-T triad. 
Since the Erwinia SAR endolysins are in a large clade of R21-like proteins, we can 
hypothesize that in this instance, the SAR domain predates the disulfide bond regulation 
(discussed further below).  
 
 98
 
 
FIG. 4.2. Phylogenetic analysis of lysozymes and GH24 proteins. An unrooted 
maximum likelihood tree is presented where R21-like SAR lysozymes are in blue, 
P1Lyz-like SAR lysozymes are in red, and soluble lysozymes are in black. GH24 
SAR endolysins are represented in green and soluble GH24 proteins are in purple. 
For explanation of numbered features, see text. Branch support values are shown 
before each node in red. All branches with a support value less than 0.5 were 
collapsed. Branch lengths represent relative divergence although the unit of length is 
arbitrary. 
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BcepMu gp22 is a putative SAR transglycosylase 
Previously, it was thought was that all SAR endolysins were homologs of T4 E, a 
true lysozyme (74, 133, 158, 159). E uses a E-8x-D-5x-T catalytic triad in a hydrolase 
mechanism to cleave the β−1, 4 linkages between MurNAc and GlcNAc units (Fig. 1.3). 
The Glu residue acts as an acid to protonate the glycosidic linkage. The nucleophile at 
position 20 abstracts a proton from a water molecule, which then attacks C1 of the 
MurNAc moiety. The Thr at position 26 interacts with and stabilizes the water molecule 
involved in the hydrolysis of the glycosidic bond. What results is a nucleophilic 
substitution reaction in which the remaining peptidoglycan chain is the leaving group 
along with the glycoside oxygen (73). The cleavage mechanism results in inversion (β to 
α conformation) of the anomeric carbon. 
Like lysozymes, transglycosylases like R from phage lambda cleave the β−1, 4 
linkages between MurNAc and GlcNAc units (Fig. 1.4). The catalytic center of a 
transglycosylase is structurally similar to that of the lysozyme, except for the absence of 
the catalytic Asp in the transglycosylase (120). As with the muramidase reaction, the 
transglycosylase mechanism uses a catalytic carboxylic acid to protonate the glycosidic 
linkage (121). After the formation of a stable intermediate involving the N-acetyl group 
of the MurNAc moiety, the glycosidic linkage oxygen leaves with the remainder of the 
PG chain. The catalytic Glu then acts as a base to remove the C6 hydroxyl proton of the 
intermediate. The final step occurs when an intramolecular, nucleophilic attack at C1 by 
the C6 oxygen collapses the intermediate. This final step transfers the muramoyl bond 
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back onto the C6 hydroxyl group of the same muramic acid moiety.  This results in the 
formation of a non-reducing, 1, 6-anhydro-N-acetylmuramyl product.  
Burkholderia phage BcepMu contains a putative GEWL-type LT that may be a 
SAR endolysin. BcepMu thus represents yet another new class of SAR endolysins. We 
were interested in determining the relationship between the SAR LTs and the soluble 
LTs.  More specifically, we wanted to know if the SAR LTs evolved independently of 
the other LTs. The importance of this relationship is that if the two groups evolved 
independently (i.e. clade separately), we may be able to infer that the SAR domain was 
acquired early in LT evolution. To determine these evolutionary relationships, 
phylogenetic tree analysis of lambda R and GEWL LTs was performed (Fig. 4.3).  
Unlike the GH24 SAR endolysins, the putative LT SAR endolysins (Fig. 4.3, red) are 
mostly grouped together in a clade highlighted in feature 1.  An outlier of feature 1 is the 
Pseudomonas phage B3 (21). When analyzed by TMHMM, the B3 LT is predicted to 
have two N-terminal TMDs and an N-out, C-out topology making it a putative 
membrane bound LT. 
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FIG. 4.3. Phylogenetic tree of lytic transglycosylases. An unrooted maximum 
likelihood tree is presented where lambda R homologs are in blue, GEWL homologs 
are in black, and GEWL SAR endolysins are in red. For explanation of numbered 
features, see text. For explanation of numbered features, see text. Branch support 
values are shown before each node in red. All branches with a support value less 
than 0.5 were collapsed. Branch lengths represent relative divergence although the 
unit of length is arbitrary.  
 
 
The evolutionary origin of the soluble GEWL LT from Liberibacter phage SC2 
(feature 2) is difficult to resolve due to a polytomy.  The soluble GEWL LT in this 
feature from Pseudomonas phage phiKZ appears to be related to the lambda R-like 
protein from Rhodothermus phage RM378.  This suggests that GEWL LTs and lambda 
like LTs may share a common ancestor. Feature 3 shows a predicted relationship 
between the SAR GEWL protein from Klebsiella phage KP15 and soluble GEWL LTs 
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from phages SC1 and phiSboM-AG3, although the exact origin is difficult to resolve due 
to a polytomy. In this case, perhaps KP15 picked up its SAR domain in a recent transfer 
event. The LT tree was derived with the E. coli Stl35 (40) (Fig. 4.3, green). Slt35 groups 
in the major clade containing the lambda-like LTs possibly suggesting horizontal gene 
transfer between bacteria and phage (discussed further below).  
 
ΦV10 gp29 has PG degradation activity 
Many phage endolysins (8 %) are classified as general function chitinases by 
conserved domain analysis. We were interested in determining the enzymatic substrate 
specificity of the phage chitinases, more specifically, if they could degrade bacterial 
PG. The chitinase from phage ΦV10, gp29, was chosen for further experimental 
analysis. Phage ΦV10 is a temperate phage specific for EHEC strain O157:H7 (112). 
As expected, cells expressing the presumably cytoplasmic gp29 did not lyse. 
Unexpectedly, the addition of CHCl3 did not achieve lysis.  However, when cells 
expressing gp29 were subjected to a round of freeze-thawing, culture clearing was 
observed, suggesting the gp29 is CHCl3-sensitive. Despite classification as a chitinase, 
purified ΦV10 was shown to have activity against bacterial PG by turbidometry 
analysis (Fig. 4.4). Several Pseudomonas chitinases have been shown to have dual 
chitin and PG degrading activities (149).  However, the chitinase activity of ΦV10 gp29 
was not detectable using a colorimetric colloidal chitin azure assay. This assay 
measures chitinase activity using chitin from crab shells covalently linked to Remazol 
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Brilliant Violet 5R dye as a substrate. Chitin degradation is measured as a function of 
dye release.   
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FIG 4.4. ΦV10 gp29 has PG degradation activity. The endolysin from phage ΦV10 
is a member of the glycoside hydrolase family 19 (GH19) with a predicted chitinase 
function but shows PG degradation activity. The indicated amount of pure protein 
(approx. 1mg/mL) was added to 100μg M. lysodeikticus cells. Optical density was 
monitored over time. Pure T4 E acted as an assay control. 
 
 
Amidase phylogenetic analysis 
Overall, the amidases show very little sequence divergence. Since a majority of 
the amidase containing phages are similar T7-like phages, we were interested in 
knowing if the amidase proteins were also similar to each other. To address this, 
phylogenetic analysis was performed on the amidase sequences. We were also interested 
in the possible evolutionary relationships between phage and bacterial enzymes, the E. 
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coli amidases involved in cell wall turnover, AmiA, AmiB, and AmiC were included in 
the amidase analysis (Fig. 4.5). The amidases form two major clades (Fig. 4.5, features 1 
and 2). Roseophage SIO1 effectively acts as an outgroup, but is a distant relative of 
phage T7 (123). The E. coli amidases group in clade 1 with the bulk of the phage 
amidases suggesting possible host-to-phage horizontal transfer (discussed further 
below). The host amidases are most related to the amidases from the T4-like 
Acinetobacter myophages Ac42 and Acj9. These phages are unusual because most (28 
of 34) of the amidase containing phages are T7-like podophages. BLAST analysis of 
AmiA, AmiB, and AmiC show homology with amidases from other bacterial species 
including Shigella, Salmonella, and Klebsiella.  
 
Peptidase phylogenetic analysis 
In contrast to the amidases, the peptidases display low sequence similarity. This 
may suggest isolated evolution of members of this class. To test this, phylogenetic 
analysis was performed on the peptidases sequences (Fig. 4.6). The tree is rich in 
polytomies, possibly due to the high sequence diversity, making analysis difficult. 
Again, a polytomy may represent a speciation event, possibly through species isolation, 
but can also mean that there is insufficient information to form a bifurcated branch. As 
with the amidase tree, E. coli metallopeptidase MepA, which is involved in PG turnover, 
was included in the analysis (89). Rather than act as an outlier, MepA clades with the 
phage peptidases suggesting a possible gene transfer event. BLAST analysis shows 
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MepA homologs in other Gram-negative species such as Shigella, Salmonella, and 
Erwinia.  
An interesting find among the peptidases are phages SP6 and K1-5, which infect 
Salmonella and E. coli, respectively (38, 123). SP6 and K1-5 are members of the T7 
supergroup. T7 and its homologs encode gp3.5 which acts as an amidase for host cell 
lysis. T7 gp3.5 also binds to and inhibits T7 RNA polymerase (94) to aid in the 
transition from transcription to replication and  packaging of phage DNA (168). As 
members of the T7 supergroup, SP6 and K1-5 were expected to encode gp3.5-like 
amidases rather than peptidases. Genome analysis reveals that SP6 and K1-5 are more 
closely related to each other than they are other members of the T7 supergroup, thus they 
have been placed in their own ‘SP6 group’ within the T7 supergroup (123). The 
divergence of the SP6 group from other members of the T7 group may explain why 
these phages do not have T7-like amidases. 
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FIG. 4.5. Phylogenetic tree of amidases. An unrooted maximum likelihood tree is 
presented where phage amidases are in black and E. coli amidases are in red. For 
explanation of numbered features, see text. Branch support values are shown before 
each node in red. All branches with a support value less than 0.5 were collapsed. 
Branch lengths represent relative divergence although the unit of length is arbitrary. 
 
 
The transfer of genes from phage to bacteria occurs frequently (25, 102) and the 
transfer of genes within phage communities has been well established (36). The amidase 
and peptidase phylogenetic analyses presented here may represent a case of a phage 
acquiring and using a host gene. A host autolysin could likely serve a phage well as an 
endolysin. In the context of a phage infection, endolysins are exported by a holin. Holins 
form non-specific lesions in the IM and function irrespective of the endolysin. It is 
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FIG. 4.6. Phylogenetic tree of peptidases. An unrooted maximum likelihood tree is 
presented where phage peptidases are in black and the E. coli peptidase MepA is in 
red. Branch support values are shown before each node in red. All branches with a 
support value less than 0.5 were collapsed. Branch lengths represent relative 
divergence although the unit of length is arbitrary.
 
 
reasonable that soluble endolysins of phage using the classic lysis paradigm are 
interchangeable and could possibly be replaced with a host protein of the same function.  
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Discussion 
 
SAR endolysin sub-classes 
So far, among T4 E homolog SAR endolysins, two subclasses have been 
established: those that contain Cys residues in their SAR domains and those that do not. 
Those that contain Cys residues like P1 Lyz are presumably regulated by a disulfide 
bond isomerization after release of the SAR domain from the bilayer. Those that do not, 
like R21, are hypothesized to be activated by refolding of the active site upon SAR 
domain release. The disulfide bond regulated SAR endolysins can be further broken 
down into two sub-categories based on catalytic triad. Those that contain an ECT triad 
are most likely regulated by an inactivating disulfide as seen with P1 Lyz.  A few 
disulfide bond regulated SAR endolysins (Lyz103 and others) use the canonical EDT 
triad. All of the members of the R21-like SAR endolysins found in this search use an 
EDT triad. Of noted interest were the phages that contain a soluble T4 E homolog with 
an ECT triad. These proteins could be the missing link between P1 Lyz like SAR 
endolysins and soluble T4 E homologs (discussed in more detail below). 
Generally, SAR endolysins can also be broken into three classes distinguishable 
by the distance of the catalytic residues from the SAR domain (Fig 4.7). P1 Lyz and 
Lyz103 represent a class whose catalytic residues 16 residues or farther from the SAR 
domain. Since the catalytic triad of these proteins lies far into the periplasm, it is 
reasonable that in order to prevent premature lysis, these SAR endolysins must have a 
more substantial, dedicated negative regulation mechanism in the form of DSB 
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inactivation. In this class, the SAR domain contributes only the free sulfhydryl and is not 
necessary for activity if exogenous reductant like DTT is added to the culture (74, 158). 
R21 represents a second, middle class whose catalytic residues lay 6 to 10 residues from 
the SAR domain. These proteins are dependent on the release of the SAR domain for 
proper folding of the catalytic cleft. It is thought that this refolding is SAR domain 
specific, in that the P1 Lyz SAR domain cannot activate R21 (133). Bcep22 gp79 
represents the third class of SAR endolysins in which the catalytic residue(s) is 
positioned directly adjacent to the end of the SAR domain. These SAR endolysins may 
be regulated by simple membrane proximity in which the catalytic residues are held 
close to the membrane and ‘out of reach’ from the PG. This question would be answered 
by testing a Bcepp22 gp79 construct in which the SAR domain was replaced by a 
cleavable secretion signal. If the protein is regulated by membrane proximity, the 
expectation would be that secretion of the periplasmic domain would result in rapid 
lysis. However, when such a construct was induced, no lytic activity was observed, nor 
was there any detectable protein accumulation, suggesting that this protein is unstable 
(data not shown). 
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FIG. 4.7. Alignment of SAR endolysins by catalytic residues. SAR endolysins fall 
into three sub-classes defined by the distance of the catalytic triad from the SAR 
domain. Here, the N-terminal domains of SAR endolysins are aligned by their 
catalytic residues. The SAR domain is highlighted in yellow and catalytic residues in 
blue.  
 
 
The argument above addresses the question of why we do not see SAR 
endolysins in the other classes of endolysins such as the amidases and peptidases. The 
catalytic residues in these two classes of proteins lie much further from the N-terminus 
of the protein making negative regulation of a membrane tethered amidase or peptidase 
problematic. The catalytic cleft of amidases lies in the center of the protein (30) as 
opposed to in an N-terminal lobe as it is with lysozymes and LTs. It is conceivable that 
this arrangement of the catalytic cleft is not conducive to negative regulation and thus 
the endolysin must be sequestered in the cytoplasm during the morphogenesis period. 
Among the SAR endolysins, the most extreme case in terms of catalytic residue distance 
from the SAR domain is seen in Vibrio phage K139. In this instance, the catalytic Glu 
lies 33 residues from the end of the SAR domain (Fig. 4.6) however, K139 uses a 
catalytic Cys analogous to Cys51 of P1 Lyz and has an upstream Cys analogous to C44 
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of P1 Lyz. So, despite the large distance from the SAR domain to the catalytic triad, 
tethered K139 would remain covalently inactivated, presumably in a manner similar to 
P1 Lyz. 
 
Evolution of phage lysis 
In general, there are three possible models for the evolution of dsDNA phage 
lysis. The first model places the SAR paradigm before the canonical paradigm. Since a 
SAR endolysin can lyse a cell without a holin, it is the simplest, self-contained lysis 
protein. Thus, the earliest lysis systems could have contained only a SAR endolysin. A 
primordial, SAR endolysin-only system would be somewhat inflexible in regards to lysis 
timing. This simple paradigm would have developed a more fine tuned timing 
mechanism by adding a holin to allow for synchronous release and activation of the 
protein. The holin would only have to form lesions large enough to deplete the PMF (i.e. 
a pinholin). The next step towards the classic lysis paradigm is the development of the 
holin to one that forms holes large enough to allow a soluble, cytoplasmic endolysin 
passage. Interestingly, the holin of phage P1 complements lambda ΔS (157), despite the 
fact that the P1 endolysin is a SAR protein. Thus phage P1 could represent this step in 
lysis evolution. If P1 Lyz were to lose its SAR domain and fold in the cytoplasm, it 
could hypothetically still be released into the periplasm by holin triggering. In fact, 
several phages contained soluble T4 E homologs that have the P1 Lyz like ECT catalytic 
triad. Perhaps these proteins represent this step in lysis evolution. From here, the protein 
need only gain the beneficial Cys to Asp mutation in the catalytic site, as it has been 
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shown that the Cys to Glu mutation in T4 E results in a 20% decrease in catalytic 
activity (58).  
A second model is that the two component system consisting of a canonical, 
cytoplasmic endolysin and a large-hole holin came first in the evolution of phage lysis. 
This would require the acquisition of a SAR domain affixed to a cytoplasmic endolysin. 
Since holin genes and endolysin genes are adjacent in the lysis cassette, a possible 
mechanism for this would be a partial gene duplication event that placed a TMD at the 
N-terminus of the endolysin. If this duplication leads to a successful gene fusion, the 
endolysin could become membrane bound. Previous experiments have shown that SAR 
endolysins are capable of lysis in the membrane by proximity (74), thus a membrane 
bound protein would presumably not allow for lysis time modulation. The TMD could 
evolve to a SAR domain by mutation of hydrophobic residues to weakly hydrophobic 
residues such as Ala. At this point, the pseudo-SAR endolysin could evolve a control 
mechanism for lysis timing by developing a mode of regulation based on its dynamic 
membrane topology.  
An alternative to the above described models is that the canonical lysis paradigm 
and the SAR lysis paradigm originated and evolved independently of one another. This 
isolated evolution does not mean, however, that both holins and endolysins evolved 
separately. For example, a single holin could have evolved and then lent itself to other 
phages by horizontal gene transfer. Due to the variation seen in endolysin mechanisms 
(i.e. lysozyme, amidase, etc.) it is difficult to conclude if any one endolysin mechanism 
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predates the others. The phylogenetic trees presented do not have clear roots 
complicating any attempt to predict a common ancestral endolysin. 
Overall, dsDNA phages of Gram-negative hosts have developed a rapid and 
malleable method by which to lyse cells. The holin-endolysin coupling allows for 
adaptability and optimization since single amino acid changes in the holin result in 
drastic changes in lysis time (153). Despite its possible position as the most primitive 
lysis system in dsDNA phages, the SAR endolysin system remains strongly represented 
composing a large portion (71 of 279 or 25%) of endolysins found in this search. The 
utility of the SAR endolysin as a well controlled, yet rapidly dispersed lysis protein has 
maintained it in the gene pool and has possibly allowed for its emergence among other 
muraminidase mechanisms.  
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 CHAPTER V 
SAR ENDOLYSINS AS POTENTIAL DRUG TARGETS 
Introduction 
Enterohemorrhagic Escherichia coli (EHEC) is the causative agent of many 
cases of food poisoning and can cause the deadly hemolytic uremia syndrome (HUS) in 
children and the elderly. The disease state associated with EHEC is caused by the Shiga 
toxin (Stx). Stx is secreted by several human pathogens including Shigella dysentariae, 
E. coli O157:H7, and E. coli O104:H4. E. coli pathogens that carry the toxin are 
generally referred to as Shiga toxin-producing E. coli (STEC). According to recent 
estimates by the Centers for Disease Control, 265,000 cases of STEC are reported each 
year worldwide. Cases of EHEC are on the rise worldwide and over 2,000 cases were 
reported due to the most recent outbreak in Germany. 
The shiga toxin, Stx2, encoded by STEC is in the AB5 family of toxins. The Stx2 
toxin proteins form a complex composed of a monomer of subunit A and a pentamer of 
subunit B. Subunit A is an N-glycosidase that cleaves an adenine residue from the 28S 
RNA of the 60S ribosomal subunit while the B pentamer is responsible for endothelial 
cell invasion (78). The Stx2 toxin genes of STEC strains are transcribed from the late 
promoter of a lambdoid prophage along with the phage lysis genes (Fig. 1.11).  STEC 
strains typically have >20 prophages, but in general only one can give rise to viable 
phage particles, while the others are cryptic. For example, the active, Stx encoding 
prophage of O157:H7 strain EDL933 is 933W (61).  
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As with lambda, the late promoter of 933W, pR’, is induced after prophage 
induction of the vegetative cycle. Upon commitment to the vegetative cycle, the 
prophage must excise from the host chromosome, replicate DNA, and turn on the late 
genes, which include the morphogenesis and lysis genes. To induce the late pR’ 
promoter, Q, the phage encoded anti-terminator binds to Q utilization sites (qut) and then 
to the RNA polymerase, allowing read-through of downstream terminators (160).  
During STEC infections, spontaneous prophage induction occurs in a fraction of 
the cell population in the gut (81).  In addition, treatment with any DNA-damaging 
antibiotics causes population-wide induction by inducing the SOS response. The phage 
protein responsible for repressing the lytic promoters during lysogeny, CI, is a homolog 
of the SOS response repressor protein LexA. DNA damage activates RecA, the 
universally conserved bacterial recombinase/co-protease, leading to cleavage of both 
LexA and the LexA-like CI repressor (79). Thus not only are all the LexA-repressed 
promoters derepressed (the SOS response), the prophage is also induced.  Consequently, 
DNA damaging antibiotics such as norfloxacin, a gyrase inhibitor, exacerbate EHEC 
infections and are not recommended for therapy. 
EHEC contains the LEE pathogenicity island, which encodes a type III secretion 
system (5). The secretion system supports the release of proteins responsible for cell 
adhesion, but not the Stx2 toxin. A recent study shows that the Stx2 toxin relies on 
phage induced lysis to escape the cell (124). When O157:H7 strain EDL933 was induced 
for the 933W prophage, Stx2 was found extracellularly. However, when a mutant 933W 
ΔSR prophage, lacking the holin and endolysin genes, was induced, Stx2 was completely 
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restricted to the bacterial cells. Thus, it is the phage’s lysis machinery alone that is 
responsible for toxin release.  
Inspection of R933W, the muralytic enzyme of 933W, suggests that it is a SAR 
(Signal Anchor Release) endolysin. SAR endolysins are signaled for secretion to the IM 
by the Sec translocon, and are anchored in an inactive conformation with their catalytic 
residues in the periplasm (159). The SAR domain is maintained in the energized bilayer. 
PMF depletion by the holin causes synchronous release of the SAR endolysin resulting 
in rapid lysis (Fig. 5.1). In the absence of the holin, the SAR domain will spontaneously 
release from the membrane resulting in gradual, holin-independent lysis. This 
characteristic of SAR endolysins makes the holin a poor target for drug development. If 
the holin function is disrupted, toxin accumulation would continue until SAR endolysin 
mediated lysis. The holin functions independently of the endolysin. If the SAR endolysin 
function is disrupted, then the holin will still trigger immediately depleting the PMF, 
killing the cells. In the context of an Stx phage infection, toxin would be trapped in the 
dead cells. This makes the SAR endolysin a potential drug target in EHEC infections. 
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FIG. 5.1. SAR endolysins lyse cells rapidly with a holin. In the absence of a holin, 
SAR endolysins release from the membrane spontaneously resulting in gradual lysis. 
In the presence of a holin, lysis occurs rapidly. (●, black) MG1655 ΔfhuA lacIq pQ 
pR’(S,R,Rz,Rz1)933W (■, red) MG1655 ΔfhuA lacIq pQ pR’(SamR,RzRz1)933W. 
 
 
Materials and methods 
 
Bacterial strains and growth conditions   
 The Escherichia coli strains XL1-Blue, MC4100, and MG1655 ΔfhuA lacY- lacIq, 
and RY8797 ΔcheA have been described (53, 127, 133). Standard conditions for the 
growth of cultures and the monitoring of lysis kinetics have been previously described 
(29, 127).  All bacterial cultures were grown in standard LB medium, supplemented with 
100 μg/ml ampicillin when appropriate. When indicated, isopropyl β-D-
thiogalactopyranoside (IPTG) and dinitrophenol (DNP) were added to final 
concentrations of 1 mM and 10 mM, respectively.  At the indicated time, 6-
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nitroquinolin-8-yl 2,3,3,3-tetrafluoro-2-methoxypropanoate (ChemBridge, San Diego, 
CA), designated here as 67-J8, was added to the specified final concentration. At the 
indicated time after induction, an aliquot of cells were removed from an aerating culture 
and phase-contrast images were taken using a Nikon Digital Sight DS-5M camera on a 
Nikon OPTIPHOT microscope. 
 
DNA procedures and plasmid construction 
Procedures for the isolation of plasmid DNA, DNA amplification by PCR, PCR 
product purification, DNA transformation, site-directed mutagenesis, and DNA 
sequencing have been previously described (52, 126, 128). The construction of the 
plasmid pP1 Lyz, a derivative of pJF118EH, has been described previously (45, 159). 
The plasmid pZER933WcHis, a derivative of the medium copy, IPTG-inducible vector 
pZE12 (86), was constructed by PCR amplifying R933W from pET41b R933W cHis 
(provided by Quingan Sun) and inserting it between the KpnI and XbaI sites of pZE12 
digested with the same enzymes. The construction of the plasmid pZER21 has been 
described previously (133). Derivative alleles were constructed using site-directed 
mutagenesis.  
 
Subcellular fractionation  
To determine whether a particular protein was present in the soluble or 
membrane fractions, 25 mls of an induced culture were collected by centrifugation at 
5000 x g and resuspended in 2 ml of buffer (0.1M sodium phosphate, 0.1M KCl, 5 mM 
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EDTA, 1 mM dithiothreitol, 1 mM phenylmethylsulfonyl fluoride, pH 7.0) and then 
disrupted by passage through a French pressure cell (Spectronic Instruments, Rochester, 
N.Y.) at 16,000 lb/in2. The membrane and soluble fractions were separated by 
centrifugation at 100,000 x g for 60 min. Equivalent amounts of the fractions were 
examined by SDS-PAGE and Western blotting as described below.  
 
SDS-PAGE and Western blotting   
 SDS-PAGE, Western blotting, and immunodetection experiments were 
performed as previously described (52). A mouse monoclonal antibody against the 
oligo-histidine epitope tag was purchased from Amersham and was used at a dilution of 
1:3000. The anti-mouse IgG horseradish peroxidase-conjugated secondary antibody was 
supplied with the SuperSignal chemiluminescence kit (Pierce) and was used at a 1:5000 
dilution. Blots were developed using the West Femto SuperSignal chemiluminescence 
kit (Pierce). Chemiluminescent signal was detected using a Bio-Rad ChemiDoc XRS. 
 
In vivo high through-put inhibitor screening 
A unique, high-diversity library containing compounds filtered for drug-like 
properties was screening using high through-put methods. The library, developed by J.S. 
Sacchettini and T.R Ioerger, contains non-redundant compounds selected for their small 
size (< 600 Da) and lack of reactive chemotypes and aggregative properties. MG1655 
ΔfhuA lacY- lacIq cells containing pZER933W cHis were grown to an optical density 
(O.D.) at 550nm of 0.2. 40 μL of the actively growing culture was added to each well of 
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384 well plate containing 10 μL of 4X LB, 4 mM IPTG and 1 μL 1 mM compound 
dissolved in DMSO. All liquid manipulations were performed using a Cybio Vario 
robot. An initial O.D. reading was taken at 550nm on a BMG Labtech Polarstar Omega 
plate reader after culture addition (and subsequent induction of R933W) and readings were 
taken every hour for five hours. Hit compounds were ones that allowed growth as 
opposed to SAR endolysin mediated lysis and were rescreened by hand. 
 
In vitro lysozyme assay 
 Lysozyme activity was assayed with the EnzChek® Lysozyme Assay Kit 
(Invitrogen, Carlsbad, CA) which measures lysozyme activity on fluorescently-labeled 
Micrococcus lysodeikticus cell walls. Two μL of 2.5 μM R933W in reaction buffer (0.1 M 
sodium phosphate, 0.1 M NaCl, pH 7.5, 2 mM sodium azide) was used in each 
experiment. 67-J8 was serial diluted, in a range from 6.5 μM to 0 μM, into wells. One 
hundred μL fluorescently-labeled M. lysodeikticus cell wall suspension was added as the 
substrate to start the reaction. Fluorescence was measured in a POLARStar Optima plate 
reader (BMG LabTech) using excitation/emission of 485/520 nm every 2 min.  
 
In vitro lysozyme assay, CHCl3 method 
 Lysozyme activity against E. coli PG was determined using a modified in vitro 
lysozyme assay. E. coli cells were grown to an O.D. of 0.6 to 0.7. Cells were pelleted 
and resuspended in 5mL cold LB. CHCl3 was added to a final volume of 10%. The 
mixture was inverted gently to mix and was allowed to settle at room temperature for 
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five min. CHCl3 was removed and cells were washed twice more with CHCl3.  CHCl3 
treated cells were added to wells containing the indicated amount of purified protein or 
lysate. Hen egg white lysozyme (HEWL) and CHCl3 treated cells alone served as assay 
controls. To prepare R933W lysate, MG1655 ΔfhuA lacY- lacIq cells containing pZER933W 
cHis were grown to an O.D. of 0.2 and were induced with IPTG. Cells were pelleted, 
resuspended in buffer (50 mM Tris, pH 8, 100 mM NaCl), and French pressed. Lysate 
was added in the indicated amounts to wells with and without compound. O.D. 
measurements at 550 nm were taken every 2 minutes using a Tecan Infinite 200 PRO 
plate reader.  
 
Tethering assay and video recordings 
 RY8797, a ΔcheA derivative of RP437 (110) that rotates only counterclockwise, 
was used for all experiments. An overnight culture of RY8797 was grown in TB at 37°C. 
The culture was back diluted into fresh TB and grown to late log phase (A550= 0.6-0.7). 
Cells were harvested, washed once with TB, and flagella were sheared in a Waring 
blender with four, seven second pulses. Cells were washed three times with TB and were 
incubated on a glass coverslip for 20 minutes with anti-flagellar filament antibody 
(provided by Dr. Mike Manson, Texas A&M University). Cells were observed by phase 
contrast microscopy in a PeCon closed cultivation perfusion chamber on a Zeiss Axio 
Observer.A1 scope affixed with an AxioCam HSm camera. Cells were equilibrated with 
TB from a Warner Model SH-27B inline heater pre-warmed to 37°C. Flow was stopped 
and video of six fields of view was taken for one min each. Flow was restored for five 
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min with TB plus 25 μM 67-J8. Flow was stopped and video was taken of six fields of 
view for one min each.  
 
Image processing and statistics 
 Individual cells were chosen from a recorded field of view based on consistency 
of spinning. Cells that stopped frequently or did not spin horizontally relative to the slide 
were not counted. For both groups, before and after compound flow, all of the cells that 
met these criteria in a given field of view were counted. Most cells in any particular field 
of view were not spinning. The most likely reason for this was incomplete shearing. To 
achieve 20-30 countable cells, six fields of view were captured for each condition. After 
video acquisition, videos were trimmed to highlight individual spinning cells using the 
Cutter option in the AxioVision software. The number of rotations of individual cells 
was counted by hand. The lowest and highest data points were thrown out of each set as 
outliers. In the ‘after-compound’ data set, three cells were thrown out because they were 
larger than cells in the ‘before compound’ data set. A caveat of the tethering method is 
the synthesis of new flagella as cells grow and divide over time. Typically, this is 
overcome by the addition of chloramphenicol. Here, chloramphenicol was not used to 
avoid any possible drug interactions with 67-J8. The size of the cells thrown out may be 
coupled with flagellar synthesis which can alter, slow, or stop rotation. Histogram 
analysis was performed using KaleidaGraph. Rotational velocities were binned in 0.5 
rotations/sec increments to account for the maximum standard error which was 0.46 in 
the ‘after compound’ data set. 
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Results and discussion 
 
R933W is a SAR endolysin 
When expressed from a plasmid, R933W lysed cells independently of holin 
triggering (Fig. 5.2A). This holin independent lysis is indicative of SAR domain 
spontaneous release from the membrane. Since SAR domain release is synchronously 
triggered due to holin-mediated membrane depolarization, it follows that addition of 
energy poisons such as DNP would have the same effect. As expected, DNP addition 20 
min after induction results in premature lysis presumably due to R933W release (Fig. 
5.2A). A subcellular fractionation of cells expressing R933W showed soluble and 
membrane bound protein of the same apparent molecular mass, characteristic of SAR 
proteins (74, 133, 159) (Fig. 5.2B).  SAR domains rely on a preponderance of weakly 
hydrophobic, neutral, or polar residues within the predicted transmembrane sequences 
(159).  In previous studies of SAR domains, replacement of 2-3 consecutive Gly or Ala 
residues eliminated the ability of the SAR domain to exit the bilayer.  Accordingly, two 
consecutive Ala residues (Ala18, Ala19) were converted to Leu residues by site-directed 
mutagenesis of R933W. Subcellular fractionation of cells induced for the double mutant 
revealed that the protein was restricted to the membrane fraction (Fig. 5.2C).  Moreover, 
the endolysin was non-lytic (Fig. 5.2A). Taken together, these data demonstrate 
unambiguously that R933W is a bona fide SAR endolysin. 
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FIG. 5.2. R933W is a SAR endolysin. (A) Induction of R933W and derivative alleles. 
(●) pZE12 R933W, (■) pZE12 R933W + 10mM DNP at min after induction, (▲) 
pZE12 R933W A18,19L. (B-C) Localization of R933W and derivatives after induction 
of the indicated plasmids. Lanes 1, 2, and 3 represent the total, soluble, and 
membrane fractions, respectively. (B) pZE12 R933W , (C) pZE12 R933W A18,19L. 
 
 
High through-put inhibitor screening 
To identify lysis inhibitors, we utilized an in vivo approach. Bacterial cultures 
harboring an IPTG inducible plasmid, pR933W, were grown to mid-log phase. The culture 
was added to wells containing inducer and compound. Using our method of in vivo 
screening, there are three possible outcomes. If the compound has no effect, R933W will 
be secreted and released from the IM lysing the cells. Addition of a toxic compound will 
result in cell growth cessation. During screening, several toxic compounds were found. 
The third outcome is that the compound inhibits SAR endolysin mediated lysis and 
results in cell growth. .  This method was appealing because it demands compound entry 
into the cell or at least past the OM and PG, since R933W functions in the periplasm. If the 
compound was unable to pass the OM or PG, then it would have no effect and would not 
be realistic as a drug. Our in vivo method also required that the compound is sustained in 
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cells. If the compound enters the cells but is metabolized, its efficacy would be reduced, 
making it a less attractive drug candidate. Nearly 8,000 compounds were screened in 
384-well format. One compound, designated 67-J8 by plate and well location, 
respectively, prevented lysis (Fig. 5.3A). The lysis inhibiting capacity of 67-J8 was 
successfully scaled up from 40 μL in 384 well plates to 25mL shaker flasks in order to 
determine mode of action (Fig. 5.3B).  
 
 
 
 
FIG. 5.3. Inhibitor screening curves. (A) In vivo lysis inhibitor screening was 
performed in high through-put format in 384 well plates as described in the text. Of 
8000 compounds, a toxic compound was found (■, red). Many compounds had no 
effect (?, blue) compared to an uninduced well (●, black), and one prevented lysis 
(designated 67-J8) (▲, green). (B) The lysis inhibiting ability of 67-J8 was scaled up 
to 25mL in a shaker flask. Cells treated with 25 μM 67-J8 at time 0 (■) did not lyse 
compared to cells with no compound (●). 
 
 
67-J8 does not inhibit R933W activity 
 Our initial motivation for high through-put screening of the compound library 
was to find compounds that inhibit the muralytic activity of R933W. To test if 67-J8 was a 
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lysozyme inhibitor, an in vitro lysozyme assay was performed (Fig. 5.4). The assay 
measures lysozyme activity using fluorescein-labeled M. lysodeikticus cell walls as a 
substrate. The cell walls are highly labeled thereby quenching fluorescence. Cell wall 
hydrolysis relieves the quenching resulting in an increase in fluorescence. Activity is 
directly proportional to the increase in fluorescence over time. Lysozyme activity of pure 
R933W (provided by Quingan Sun of the Sacchettini Lab, Texas A&M University) was 
tested in the presence of various concentrations of 67-J8. The compound had no effect 
on the activity of purified R933W versus the fluorescent substrate in vitro, suggesting that 
it is not a lysozyme inhibitor. No change in fluorescence was observed suggesting that 
67-J8 is not a lysozyme inhibitor.  
 
 
 
 
FIG. 5.4. In vitro lysozyme activity assay of R933W treated with 67-J8. Pure R933W, at 
0.05 μM final protein concentration (provided by Quingan Sun), was tested for 
lysozyme activity in the presence of 67-J8. (●, black) 6.5 μM 67-J8, (■, red) 3.25 μM 
67-J8, (?, blue) 1.625 μM 67-J8, (▲, green) 0 compound, (?, grey) 0 R933W. 
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67-J8 does not inhibit access to E. coli PG 
The above described in vitro lysozyme assay tested R933W activity against 
purified, derivatized murein from the Gram-positive bacterium, M. lysodeikticus. The 
chemical structure of PG shows considerable species-specific variation  (122). Among 
Gram negatives, the variability is in the extent of crosslinking (91) and the length of the 
glycan strands (143). Nothing is known about R933W substrate specificity.  To test 
whether the compound’s inhibitory character was PG-specific, a modified in vitro 
lysozyme activity assay was performed (Fig. 5.5). 0.1 μg (0.05 μM final protein 
concentration) of pure R933W (provided by Quingan Sun) was added to wells containing 
various amounts of 67-J8. To prepare the substrate, E. coli cells were harvested, 
concentrated, and treated with CHCl3. Presumably, after CHCl3 treatment, the E. coli PG 
is exposed and susceptible to exogenous lysozyme addition.  Lysozyme degradation of 
the PG results in cell lysis as determined by a decrease in turbidity over time. In the 
presence and absence of compound, no change in lysis was observed. This suggests that 
the compound does not hinder R933W’s access to the E. coli PG.   
 
 
 128
 
 
FIG. 5.5. 67-J8 mediated lysis inhibition is not PG specific. 0.1 μg pure R933W 
(provided by Quingan Sun) was added to wells containing the indicated amount of 
67-J8. At time 0, 100μL CHCl3 treated E. coli cells were added. O.D. readings 
were taken every 2 minutes in a Tecan Infinite 200 PRO plate reader. 0.1 μg 
HEWL was added for a control. 
 
 
67-J8 does not inhibit R933W expression or accumulation 
The experiments described above show that 67-J8 does not affect R933W activity 
or PG access. There are many other testable targets; for example, the compound could 
prevent lysis by altering protein expression. Another possibility is that SAR endolysin 
secretion or accumulation in the IM is blocked. To determine if the compound was 
altering protein expression or accumulation, samples of cells expressing R933W in the 
presence or absence of compound were assayed for protein via Western blot (Fig. 5.6A). 
No change could be seen between conditions, indicating that 67-J8 does not affect 
protein translation or accumulation. Periodically, the morphology of cells expressing 
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R933W in the presence or absence of 25 μM 67-J8 was examined (Fig. 5.6B). After 60 
minutes of induction, cells expressing R933W in the presence of compound began to round 
up and were fully spherical in shape after 120 min. MG1655 cells treated with 25 μM 
67-J8 for 120 min produced no round cells (Fig. 5.6C). The loss of rod-shape indicates 
the loss of PG integrity presumably by R933W activity. Furthermore, the effect of 67-J8 
could be immediately reversed by the addition of 10 mM DNP (Fig. 5.6D). Taken 
together, the above results suggest that R933W secretion and activation is not affected by 
67-J8 treatment.   
 
 
 
 
FIG. 5.6. 67-J8 does not alter protein expression or active protein accumulation. 
(A) At the indicated time after induction, cells expressing pR933W in the presence or 
absence of 25 μM 67-J8 were TCA precipitated. Western blot analysis indicated no 
change in total protein yield. (B) At the indicated time, pictures were taken of 
representative cells expressing R933W in the presence of 25 μM 67-J8. (C) MG1655 
ΔfhuA lacY- lacIq cells after 120 min of growth in the presence or absence of 25 
μM 67-J8. (D) The addition of DNP reverses the effect of 67-J8. MG1655 ΔfhuA 
lacIq pQ pR’ (SamR/Rz/Rz1) cells expressing pZER933W with: (●, black) no 
compound, (■, red) 25 μM 67-J8 added at time 0, (?, blue) 25 μM 67-J8 added at 
time 0, 10mM DNP added at 30 min after induction. 
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67-J8 is a general inhibitor of SAR endolysin mediated lysis 
 We were interested in knowing if the pathway affected by 67-J8 was specific for 
R933W or if it was shared with other SAR endolysins. SAR endolysins can be broken into 
two sub-classes based on the presence or absence of a Cys in the SAR domain. Those 
that contain a Cys, like P1 Lys from phage P1, are proposed to be regulated by a 
disulfide bond isomerization (158). Those without, like R21, are proposed to be regulated 
by a conformational restructuring of the active site upon SAR domain release from the 
membrane (133). R933W has no SAR domain Cys, so it is member of the R21-like class of 
SAR endolysins. The lysis inhibiting capacity of 67-J8 was tested against P1 Lyz and 
R21 (Fig. 5.7). Both P1 Lyz and R21 mediated lysis was prevented by compound addition.  
Thus the lytic step targeted by 67-J8 is common to SAR endolysins regardless of their 
regulation type. 
 
67-J8 mediated lysis inhibition is temporally dependent 
To determine how soon after induction 67-J8 acts to prevent lysis, the time at 
which the compound was added was varied (Fig. 5.8). Cells containing pR933W were 
induced with IPTG. At various times after induction, aliquots were removed and grown 
from then on in the presence of 25 μM 67-J8. Cells in which the compound was added at 
induction grew to a higher O.D. than those in which the compound was added later. 
Interestingly, when compound was added 40 min after induction, cells appeared to die. 
From this, we conclude that in order to be effective, the compound must be added soon 
after induction.  
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FIG. 5.7. 67-J8 prevents lysis by other SAR endolysins. MG1655 ΔfhuA lacY- lacIq 
cells containing pZER21 (black) were induced in the presence (■) or absence (●) of 
25 μM 67-J8 at time 0. MC4100 cells containing pP1 Lyz (red curves) were induced 
in the presence (■) or absence (●) of 25 μM 67-J8 at time 0. Blue curves represent 
empty MG1655 ΔfhuA lacY- lacIq cells with (■) and without (●)+ 25 μM 67-J8 at 
time 0. 
 
 
67-J8 increases the proton motive force 
Our next hypothesis was that 67-J8 was increasing the PMF. Presumably, the 
retention of the SAR domain is dependent on the PMF, since depletion of the PMF 
results in early lysis of cells expressing a SAR endolysin. It follows that an increase in 
PMF would retain the SAR domain in the membrane, possibly explaining the lysis block 
in compound treated cells expressing SAR endolysins. In order to test this, we monitored 
the PMF  in individual E. coli cells as a function of time by recording the rotational 
speeds of cells tethered to a surface by a flagellum (125). The speed of rotation is 
proportional to the PMF over a dynamic physiological range (44). 
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FIG. 5.8. The effectiveness of 67-J8 depends on time of addition. At the indicated 
time point, compound was added to a final concentration of 25 μM to cells 
expressing R933W. (●, black) no compound, (■, red) 0 min, (?, blue) 10 min, (▲, 
green) 20 min, (▼, purple) 30 min, (?, grey) 40 min. 
 
 
Motile cells were tethered to a glass coverslip by a single flagellum by using an antibody 
against the flagellar filament. Wild type motile cells frequently stop and change 
rotational direction. To avoid these pauses, a cheA mutant, in which the flagella spin 
only counterclockwise, was used in these experiments. Tethered cells were equilibrated 
for 5 min in a perfusion chamber by washing with TB from an in line heater pre-warmed 
to 37°C. Flow was stopped and video was taken for six fields of view for one minute 
each. In any one field of view, only ten to twenty percent of the cells rotate, as has been 
observed previously (125). Twenty-five μM compound in TB was then flowed in for five 
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min after which flow was stopped and video was taken as described above. The rotations 
of individual cells spinning at a constant rate were counted by hand during a 20 second 
span of video and rotational velocity (rotations/sec) was calculated (Fig. 5.9). Criteria for 
inclusion in the dataset and removal of outliers are described in materials and methods. 
Before compound treatment, the average rotational velocity was 2.6 rotations per 
second. After five min of compound treatment, the average rotational speed increased to 
3.4 rotations per second. Although a large variance was observed within each dataset, a 
general trend can be seen. After the addition of compound, the histogram suggests that 
the number of cells at the lower rotational velocities (between 1.5 and 4.5 rotations per 
sec) begins to drop and the number of cells higher than 4.5 rotations per second begins to 
increase. The increase in rotational speed after compound treatment suggests an increase 
in PMF.  
 
Conclusions 
Of nearly 8,000 compounds screened with our in vivo assay, only one compound, 
designated as 67-J8, was successful in preventing SAR endolysin-mediated lysis. 
However, when the compound was tested for inhibition of R933W activity against M. 
lysodeikticus and E. coli cell walls, no inhibition was detected over the concentration 
range examined.  67-J8 was shown to increase the average rotational velocity of cells 
suggesting that it increases cellular PMF. SAR domains are maintained as meta-stable 
transmembrane domains within the context of an energized bilayer until PMF depletion 
by holin. 
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FIG. 5.9. 67-J8 increases proton motive force. Cells were tethered to a glass slide 
and rotational velocity of individual cells was calculated before and after 
compound treatment. The number of cells displaying the indicated rotational 
velocity before compound (black) and after compound (red) is plotted as a 
combined, overlaid histogram. The statistics for each data set are given. 
 
 
Membrane poisons such as DNP and cyanide mimic the depolarization effect of the 
holin and have been shown to prematurely release SAR endolysins (74, 133, 159). In the 
absence of holin, SAR endolysins spontaneously release from the membrane resulting in 
gradual lysis. If the PMF is stabilized or increased, presumably, the SAR domain would 
be retained in the membrane longer. The increase in PMF accounts for the effectiveness 
of 67-J8 against other SAR endolysins, regardless of their regulation style. The 
compound has little to no effect on wild type cell growth and morphology (Fig. 5.7, 
5.6C), but shows a growth defect in cells expressing SAR endolysins.  
How the increase in PMF relates to the observed growth defect is not clear. Interestingly, 
deletion of the E. coli atp operon causes a 20% increase in PMF and is coupled with a 
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growth defect (65). The mode by which 67-J8 increases the PMF has yet to be 
established.  
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CHAPTER VI 
SUMMARY AND FUTURE DIRECTIONS 
 
The first SAR endolysin evidence was published in 2004 (159). Before this 
relatively recent discovery, it was assumed that all dsDNA phages of Gram-negative 
hosts used the classic lysis system typified by phage lambda. This system requires a 
holin to form large, non-specific lesions in the membrane. The lesions allow passage of 
the soluble, cytoplasmic endolysin into the periplasm, which then leads to degradation of 
the peptidoglycan. In the absence of holin function, the endolysin would be trapped in 
the cytoplasm and the intracellular infection process would continue indefinitely, with 
no lysis occurring. Thus the common view was that the endolysin is merely a reporter 
for holin activity, and the latter supported the key step in lysis.  Thus although the T4 
lysozyme was arguably one of the most studied enzymes, there was little focus on its 
role in lysis. Instead, it was mainly a model for protein folding and stability (7). The 
notion that all dsDNA phages use the classic holin-endolysin paradigm began to give 
way with the discovery that some Gram-positive phages had secreted endolysins that 
could lyse cells in a holin independent manner (118). However, in the absence of a facile 
experimental system with genetics in place, this exception to the holin-endolysin 
paradigm received little attention.  
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SAR endolysins 
The new lysis paradigm for dsDNA phages of Gram-negative hosts began to 
emerge through the study of P1 Lyz of the lambdoid phage P1 (63). The work of Dr. 
Min Xu and Dr. Arockiasamy Arulandu and Stephanie Swanson of the Sacchettini lab 
showed that induction of a plasmid expressing Lyz lysed cells without a holin (159). P1 
Lyz was shown to contain a putative N-terminal secretion signal. A sub-cellular 
fractionation, however, showed that membrane bound and periplasmic Lyz was the same 
apparent molecular mass. This suggested that the endolysin maintains the secretion 
signal that then anchors the protein to the cytoplasmic membrane, and then allows for its 
release, thus this domain was termed a Signal Anchor Release (SAR) domain (159). 
Since the protein is produced before the production of the first phage and its catalytic 
domain was present in the periplasm, it was critical that there be a regulatory system for 
preventing premature lysis. It was determined through genetic, biochemical, and 
structural analysis that in its membrane bound, inactive form, P1 Lyz is inactivated by a 
disulfide bond involving its catalytic Cys (158). The inactivating disulfide is broken by a 
Cys in the SAR domain after its release from the membrane.  
 
Shifting the SAR endolysin paradigm 
The work in this dissertation has followed from that work and has broadened the 
field in many ways. First, it has shown that a sub-class of disulfide bond regulated SAR 
endolysins exists. This sub-class is typified by Lyz103 from the Erwinia amylovora phage 
ERA103. In its membrane-bound, inactive form, Lyz103 was shown to have a disulfide 
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bond between Cys residues flanking the catalytic Glu residue (74). Although we do not 
have structural information, we can posit that the disulfide bond effectively acts as a 
‘cage’ to sequester the catalytic Glu.  The activity of Lyz103 was shown to be dependent 
on a Cys in the SAR domain. Consequently, we hypothesize that after SAR domain 
release from the membrane, a disulfide bond isomerization, mediated by the Cys in the 
SAR domain breaks the cage, activating the enzyme. An inference from bioinformatic 
analysis is that covalent inactivation is required for SAR endolysins whose catalytic 
residues lie farther from the SAR domain as these enzymes are capable of reaching the 
peptidoglycan while tethered to the membrane.  
Second, this work has demonstrated, in collaboration with Quingan Sun of the 
Sacchettini Lab, that a second class of SAR endolysins, typified by R21, exists (133). R21 
was shown to be regulated by dynamic membrane topology in which the SAR domain 
actively participates in the proper folding and creation of the active site. Unlike P1 Lyz 
and Lyz103, whose SAR domains contribute only a sulfhydryl, R21’s SAR domain was 
shown to be essential for activity. Further, at least among sequenced phages, my analysis 
indicates that members of the R21 class compose the majority (80%) of SAR endolysins.  
Moreover, SAR endolysins represent 25% of all endolysins identified in the 
genomes of phages of Gram-negative hosts. This work also revealed some SAR 
endolysins that are not homologous to T4 E, a true lysozyme. Before this dissertation, it 
was thought that all SAR endolysins were homologs of E. E has an E-5x-D-8x-T 
catalytic triad and uses a hydrolysis mechanism. Bcep22 gp79, a glycoside hydrolase 
family 24 protein, and BcepMu gp22, a transglycosylase, serve as prototypes of new 
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SAR endolysins. Additionally, phylogenetic analysis has allowed us to develop a 
hypothesis regarding the evolution of dsDNA phage lysis of Gram-negative hosts. Since 
the SAR endolysin can lyse cells in the absence of a holin, it is the simplest, self-
contained lysis protein. As such, we have proposed that the earliest lysis systems would 
have composed only a SAR endolysin. This SAR endolysin-only system would have 
developed a more fine tuned system by acquiring a holin to allow synchronous release of 
the SAR endolysin. Progression to the classic lysis system would require the loss of the 
SAR domain and development of a large-hole forming holin for cytoplasmic endolysin 
release into the periplasm.  
 
Future directions 
 Several questions regarding SAR endolysins remain. These questions involve the 
nature of the SAR domain itself. Presumably, a SAR domain supports release from the 
membrane due to the over-representation of weakly hydrophobic amino acids such as 
Ala, Gly, Cys, and Thr. A transmembrane domain (TMD) on the other hand contains 
strong hydrophobic amino acids such as Leu, Ile, and Val. It is thought that the 
hydrophobic nature of a TMD allows for a thermodynamically favorable transfer of the 
sequence from the translocon channel into the lipid membrane (154). A threshold of 
hydropathy between TMDs and SAR domains has not yet been established. The research 
in this dissertation shows that a SAR domain can be converted into a conventional TMD 
by titration of hydrophobic residues. This feature was shown to be SAR domain specific, 
i.e. P1 Lyz requires three Gly to Leu mutations (74) while Lyz103 and R21 (133) require 
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two Gly to Leu mutations. This suggests that the ability of a SAR domain to release from 
the membrane may be a function of its overall weak hydrophobicity.  
 SAR domains share characteristics of both TMDs and secreted signal sequence 
containing proteins. A SAR domain is hydrophobic enough to be recognized by the Sec 
translocon and partitioned into the membrane, although is not hydrophobic enough to 
stay there. A remaining question pertains to SAR domain transport to the membrane. 
TMDs are recognized and transported to the membrane in a Signal Recognition Particle 
(SRP) dependent pathway (85). This pathway occurs co-translationally. The pre-
protein’s signal peptide is recognized by the SRP as it emerges from the translating 
ribosome. The SRP guides the pre-protein to the SecYEG translocon and is then 
translocated by SecA. Secreted proteins are not as hydrophobic as TMDs and do not 
need co-translational secretion. These proteins use the SecB pathway. It is SRP-
independent, occurs post-translationally, and requires a chaperone, SecB. After the pre-
protein is released from the ribosome, its signal sequence is bound by SecB. SecB may 
function to protect the pre-protein from aggregating due to the hydrophobic signal 
sequence before it is translocated. SecB guides the pre-protein to the SecYEG translocon 
where it is translocated (142). Expression of a SAR endolysin in SRP (33) or SecB (72) 
depletion strains may allude to which pathway is used.  
 Another question that has yet to be answered is whether or not the SAR 
endolysin requires host factors for membrane release and subsequent refolding. Several 
chaperones function in the periplasm and any of them could play a role in the removal of 
the SAR domain from the membrane or refolding the protein to accommodate the SAR 
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domain. This may be a possibility as large conformational changes occur during P1 Lyz 
and release and refolding. Requirement of host factors can be determined using a genetic 
approach by analyzing lysis defective host mutants obtained by EMS mutagenesis. The 
possibility exists however, that the SAR domain requires no additional factor to release 
from the membrane or fold properly. Support for this comes from the immediacy by 
which a SAR domain leaves the membrane and is activated after the addition of energy 
poisons such as DNP. If this is the case, then it is possible that the amount of time a SAR 
domain spends in the membrane before releasing is directly proportional to its overall 
hydrophobicity.  
 
Concluding remarks 
 Overall, this dissertation has shifted the paradigm of the paradigm-shifting SAR 
endolysin. The SAR endolysin forced us to change how we look at endolysins.  This 
work presents alternate forms of SAR endolysin regulation and displays the diversity of 
SAR endolysin mechanisms. It has also shown the prevalence of the elegant SAR 
endolysin among dsDNA phages of Gram-negative hosts. Further study of SAR 
endolysins may even reshape how we think of protein folding, stability, and dynamics.  
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